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1 Introduction
Immunological research mainly focusses on the immune response to infections and
the pathogenesis of different diseases in humans based on the application of human
cells or mouse models. Besides humans and rodents, chickens represent the species
whose immune system is studied best [1]. In fact, the understanding of several basic
immunological mechanisms dates back to studies with chickens. Pivotal processes
like B cell and T cell development or the function of interferons, were first dis-
covered and described in chickens [2–4]. Only later, this knowledge was transferred
to the mammalian immune system. This transfer of knowledge was possible, since
the main components and mechanisms of host defence are conserved among birds
and mammals, even though the two lineages split approximately 310 million years
ago [5].
Like mammals, chickens exhibit a potent innate immune system comprising humoral
(e.g. defensines) as well as cellular components (e.g. Natural Killer (NK) cells
and macrophages) [6–8]. Additionally, chickens possess a highly developed adap-
tive immune system, including immunological memory. Analogously to mammals,
antibodies and lymphocytes constitute the two major (humoral and cell-mediated)
branches of the adaptive immune system in chickens [9, 10]. Antibodies, which
are produced by B lymphocytes, specifically target extracellular antigen, whereas
T lymphocytes constitute the cellular axis of the adaptive immune system. T lym-
phocytes can be further divided into different subsets, which are crucially involved
in the process of host defence. In terms of effector functions, T cells can be generally
classified into three main groups. Cytotoxic T lymphocytes recognise intracellular
pathogens as well as tumour cells and eliminate them to regain homeostasis. They
characteristically exhibit the Cluster of Differentiation (CD) 8 co-receptor on their
cell surface (CD8+). T helper (Th) cells, bearing the CD4 co-receptor (CD4+),
support B cells and cells of the innate immune system in fulfilling their tasks. Fi-
nally, regulatory T cells (Treg) terminate the immune response and help to restore
homeostasis. On the basis of their T cell receptor (TCR), T cells can be divided
into αβ and γδ T cells [11, 12]. While the functions of αβ T cells are well studied
in chickens and mammals, the knowledge about γδ T cells in both lineages remains
scarce.
Even though the general mechanisms of the formation of an immune response in
chickens are similar to those in mammals, chickens exhibit specialities, which distin-
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guish them from the mammalian species. The existence of the Bursa of Fabricius,
i.e. the location of B cell development, the presence of a special type of granulo-
cytes called heterophils or the absence of lymph nodes, neutrophils and classic-
al eosinophils only constitute the most evident differences between mammals and
chickens [6]. Additionally, chickens are equipped with an altered set of cytokines
and receptors [6] and exhibit a significantly higher number of γδ T cells [13].
In the past, the specialities of the embryonic development of chickens and of its im-
mune system notably contributed to the understanding of immunological processes
in mammals. Nowadays, the economic impact of poultry as a leading meat source
(regarding the feed conversion rate) [14] and its epidemiological role in spreading
zoonotic infections (e.g. Campylobacter, Salmonella and Influenza) [15], empha-
sise the importance of investigating chicken immune responses. A profound under-
standing thereof may notably contribute to maintain human and animal welfare by
ensuring low loss rearing and by limiting the risk of zoonoses.
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2 Fundamentals
2.1 T cell activation
The activation of näıve T cells and their differentiation into effector, regulatory
or memory T cells is a crucial step in the formation of an effective host defence
against pathogens of diverse origin and in regaining homeostasis. With the help of
Antigen Presenting Cells (APC), T cells encounter the antigen in secondary lym-
phoid organs: APC pick up antigen at the sites of infection, migrate to secondary
lymphoid tissues, process and present the antigen to the T cells. Only T cells
are activated, whose TCR specifically recognises discrete epitopes of the antigen.
Thereupon, they clonally expand, differentiate into effector cells and help to activate
B cells or migrate to the sites of infection [16, 17]. Recognition of the antigen by
the TCR and consecutive activation of antigen-specific T cells is a complex process
combining different signals.
2.1.1 The activation of T cells requires the presence of several signals
Recognition of the processed antigen in the Major Histocompatibility Complex I
or II (MHC I or II) molecules by a suitable specific TCR represents the first step
towards the formation of a specific T cell immune response to fight the invading anti-
gen. The contact between APC and T cells via the TCR-MHC complex, including
the CD4 and CD8 co-receptor molecules, is therefore also referred to as signal one
[18]. It constitutes the basis for T cell stimulation, but it is, by itself, not sufficient
to yield a full activation state in terms of cell proliferation, differentiation, effector
functions, cytokine production and longevity [19]. To attain a sustained and effect-
ive T cell response, the processing of additional signals is pivotal. These signals are
transduced via a variety of receptors and enhance the extent of the evolving host
defence [16, 17, 19, 20]. Besides, the necessity of costimulatory signals to generate
a functional T cell response also serves as a control system to prevent unintended
autoimmune reactions directed against self-antigens. Since costimulatory ligands on
APC are only expressed upon infection, T cells are usually solely activated by ma-
ture APC presenting the processed antigen as well as costimulatory molecules (e.g.
B7.1 and B7.2) [16, 20, 21]. If no secondary signals accompany TCR triggering,
T cells adopt an inactive, unresponsive state called anergy, undergo apoptosis in
19
B7.1	  
CD28	  
MHC	  	  
TCR	  
A
Naïve	  T	  cell	  
TCR	  
Ac6va6on	  
CD28	  
IL-­‐2R	  
IL-­‐2	  
OX40	  
Ac6vated	  APC	  expressing	  
cos6mulatory	  molecules	  
	  T	  cell	  prolifera6on,	  
differen6a6on	  and	  survival	  
Signal	  1	  
Signal	  2	  
Figure 1: Costimulatory signals allow for T cell activation.
An activated, matured APC presents the antigen (A) as well as costimulatory
molecules (e.g. B7.1) on its cell surface, thus allowing for the signal transduction by
the TCR complex (signal one) and by costimulatory receptors, e.g. CD28 (signal
two). The cooperation of both signals subsequently promotes T cell proliferation,
differentiation and cell survival, which are further maintained and enhanced by the
upregulation of additional costimulatory molecules like OX40 and IL-2R.
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Figure 2: The lack of costimulatory signals inhibits T cell activation.
A resting APC, lacking any costimulatory molecules, solely presents the antigenic
peptide (A) in its MHC molecule. As no costimulatory signals accompany TCR
triggering upon antigen encounter, the näıve T cell undergoes apoptosis, adopts
a regulatory phenotype (exhibiting the transcription factor FoxP3, FoxP3+) or an
unresponsive state called anergy.
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form of clonal deletion or differentiate into Treg [16, 17]. Figure 1 and 2 depict the
two possible fates of T cells recognising an antigen, either with or without secondary
signals.
The classic accessory molecules on T cells, which provide this signal two, can be
found, to a varying degree, on mammalian as well as on chicken αβ and γδ T cells
[10, 19, 22, 23]. They belong to three superfamilies, which are illustrated in Fig-
ure 3: the Immunoglobulin Superfamily (IGSF), the family of cytokine receptors
and the Tumour Necrosis Factor Receptor Superfamily (TNFRSF, also referred to
as TNF receptors) [24]. The most prominent members of these families and their
involvement in the process of T cell activation will be described in the following.
Immunoglobulin	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TNF	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   IL-­‐2R	   OX40	  
Figure 3: The superfamilies of costimulatory molecules.
Examples of the typical costimulatory molecules, which are involved in T cell acti-
vation. They belong to three superfamilies: the immunoglobulin superfamily, the
family of cytokine receptors and the tumour necrosis factor receptor superfamily.
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2.1.2 Costimulatory signals transmitted via members of the immuno-
globulin superfamily
The immunoglobulin superfamily comprises different costimulatory molecules, adopt-
ing important roles in T cell stimulation. All representatives of the IGSF exhibit a
conserved structural feature in their extracellular domain, namely immunoglobulin-
like domains whose number varies among different family members.
The CD2 receptor on T cells, for instance, interacts with its ligand Lymphocyte
Function-associated Antigen 3 (LFA-3, also called CD58) on APC to improve the
cellular interaction between APC and T cells by stabilising intercellular contact
and maintaining the ideal spacing for TCR-ligand interactions [19, 25]. Addition-
ally, CD2 stimulation cooperates with TCR triggering in activating intracellular
signalling cascades leading to differentiation, proliferation and effector functions
[26].
While CD2 is already expressed by resting T cells [27], Inducible T cell Costim-
ulator (ICOS), i.e. another costimulatory member of the IGSF, is considerably
upregulated when αβ and γδ T cells are activated [28]. The binding of its ligand
ICOSL (also known as B7-H2) on APC positively influences αβ T cell responses,
especially the formation of follicular helper T (Tfh) cells and of different T helper
subsets (Th1, 2, 17) [29]. ICOS probably induces similar intracellular pathways as
the most prominent member of the immunoglobulin superfamily, CD28. Hence, it
complements the effects of CD28 on proliferation, cytokine production and survival
[29].
Studies characterising the involvement of CD28 in T cell activation long dominated
the investigations of costimulatory requirements for T cell responses. The CD28
receptor is constitutively expressed on virtually all murine, on all chicken and on
a great majority of human αβ T cells [30–32]. Additionally, it is reported to be
present on a subset of resting γδ T cells in humans and chickens and is upregulated
on activated murine and avian γδ T cells [33–35]. Its ligands B7.1 (CD80) and B7.2
(CD86) are expressed on activated APC. CD28 is crucially involved in the initial
process of T cell stimulation. Signals via CD28 e.g. support the expression of the
anti-apoptotic factor B cell lymphoma-extra Large (Bcl-xL) [36], promote the tran-
scription of the growth factor Interleukin (IL)-2 [37] or stabilise messenger RNA
(mRNA) of Tumour Necrosis Factor α (TNFα), Interferon γ (IFNγ) or IL-2 [38].
Thereby, CD28 triggering constitutes the basis for T cell proliferation, differentia-
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tion and survival. While the CD28 signalling initialises T cell activation through
the mechanisms named above, other molecules notably contribute to the generation
and maintenance of an effective T cell response.
2.1.3 Costimulatory signals transmitted via members of the cytokine
receptor family
The interleukins IL-2, IL-7 and IL-15 are required for the homeostasis and devel-
opment of lymphocytes, concerning αβ as well as γδ T cell subsets [20, 22]. Upon
T cell activation via antigen encounter, these cytokines and their respective recep-
tors are upregulated and are involved in the expansion of the antigen-specific subsets
of T cells [39].
Besides IL-2, IL-7 and IL-15, which provide signal two, additional interleukins, for
instance IL-4, IL-12 and IL-23, further affect T cell responses upon inflammation.
During the process of T cell stimulation, the latter promote the differentiation of
activated T cells into different T cell phenotypes [17]. Therefore, they are also re-
ferred to as signal three, as they define the evolving effector T cell subsets [17].
Since IL-2 and IL-12 were used in this study to stimulate chicken splenocytes in
vitro, the role of IL-2 and IL-12 in the process of T cell activation is briefly dis-
cussed in the following.
IL-2 and its receptor (IL-2R) exert pleiotropic effects on a great variety of cells,
comprising e.g. B cells, NK cells and oligodendroglial cells [40–42]. Besides its
widespread implication in the generation of an immune response, the most promi-
nent function of IL-2 is its role as a major T cell growth factor for αβ as well as
γδ T cells [43, 44]. The IL-2R is a heterotrimer comprising three subunits, namely
IL-2Rα (also known as CD25) [45], IL-2Rβ (also shared by the IL-15R) [46] and
IL-2Rγ (also shared by the receptors IL-7R and IL-15R) [47]. While resting T cells
do not significantly express the functional IL-2R nor produce IL-2, both molecules
are strongly upregulated upon TCR triggering. By promoting cell cycle progres-
sion, IL-2R signals favour T cell proliferation and differentiation in an autocrine
or paracrine manner [48]. The extent and period of T cell activation is thereby re-
stricted by the amount of secreted IL-2 and surface-expressed IL-2R. It promotes the
differentiation of activated CD4+ cells into Th1 and Th2 subsets by either inducing
growth factors necessary for Th1 development (IL-12Rβ2 chain and the transcription
factor T-bet) [49] or those for Th2 development (IL-4 and IL-4Rα chain) [50, 51].
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Furthermore, IL-2 is involved in priming CD8+ T cells during initial infections for
expansion of CD8+ memory T cells upon secondary antigen encounter [52]. Ad-
ditionally, IL-2R signalling is also reported to exhibit regulating and restraining
properties in vivo, as it restricts Th17 differentiation, for instance [53]. With its
crucial role in the development of Treg [54] and supporting the activation-induced
cell death of repeatedly stimulated T cells [55], IL-2 prevents the evolution of au-
toimmunity and ensures homeostasis after an immune response.
Besides IL-2, IL-12 also displays a wide range of effects observable in innate as well
as in adaptive immune responses. It acts as signal three to drive T cell differen-
tiation during the activation process. IL-12 is a cytokine, predominantly secreted
by phagocytic cells upon bacterial and parasitic infections and by activated APC
[48]. Its corresponding receptor IL-12R can mainly be detected on NK cells, on
activated CD4+ and CD8+ T cells and on murine γδ T cells [56, 57]. The receptor
is composed of two subunits, IL-12Rβ1 and IL-12Rβ2, where the expression of the
signalling component IL-12Rβ2 is more limited, arguing for a mechanism to regulate
IL-12 effects [58, 59]. As mentioned above, IL-2 as well as IFNγ can promote the up-
regulation of IL-12Rβ2 [49, 60]. They allow for the proliferation and differentiation
of specialised T cell subsets by a positive feedback mechanism: with upregulation of
IL-12R and binding by IL-12, activated T cells increase the production of IFNγ and
IL-2. In an autocrine way, the latter promote the upregulation of IL-12R, sensitising
the cells for IL-12. Via this positive feedback loop, activated T cells themselves add
to create the necessary environment to differentiate into Th1 cells [48]. Signals via
IL-12R therefore constitute the main impulse for the generation of an effective Th1
response [61].
2.1.4 Costimulatory signals transmitted via members of the tumour
necrosis factor receptor superfamily
Only recently, the third group of costimulatory molecules, namely members of the
Tumour Necrosis Factor Receptor Superfamily (TNFRSF), together with their li-
gands (Tumour Necrosis Factor Superfamily, TNFSF, also referred to as TNF li-
gands), emerged as a key player in providing secondary signals essential for the
generation of a potent T cell response. The costimulatory receptors 4-1BB, CD27,
CD30, Glucocorticoid-Induced TNFR-Related protein (GITR), Herpesvirus Entry
Mediator (HVEM) and OX40, together with their respective ligands (4-1BB/4-1BBL,
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CD27/CD27L, CD30/CD30L, GITR/GITRL, HVEM/HVEML, OX40/OX40L), are
pivotal for the preservation of T cell activation following the initial costimulatory
effects of the CD28-B7 system [62]. The mutual relation among the different co-
stimulatory TNFRSF members and their relation to CD28 in the complex process
of T cell activation is not yet fully understood. It remains unclear whether each
receptor has an indispensable function for the generation of a fully effective T cell
response or if some of them share a certain redundancy in their effects [24]. Past
studies indicate that their impacts appear at different times during stimulation,
thus permitting to sustain the activation process [24]. While CD27 is constitutively
expressed on T cells [17] and its signalling probably supports the primary clonal
expansion, OX40 and 4-1BB are induced in later activation states to ensure the
longevity of the T cell response by supplying anti-apoptotic signals [24, 63]. For
OX40 and CD27 it was already shown by Akiba et al. [64] that their costimulatory
effects on T cells operate independently of CD28 signals in vitro, but that their ex-
pression is promoted by CD28 involvement [63, 65] and that they cannot supersede
its contributions to the initial activation process [63].
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2.2 The tumour necrosis factor receptor superfamily
The costimulatory members of the TNFRSF, which are described above, constitute
only one functional branch of the whole superfamily. Up to now, 29 genes for TNF
receptors were detected in the human genome. In mice, three additional genes were
described encoding for receptors lacking human homologues [66]. The TNF recep-
tors coordinate the immune reaction against malignant cells and pathogens from
the onset of the response to its controlled elimination and thus notably add to host
defence and homeostasis. They are involved in mobilising effector cells, sustaining
their longevity, recruiting stromal cells by creating an inflammatory milieu, but also
in promoting activation-induced cell death to restore the initial state [67].
2.2.1 The structure of tumour necrosis factor receptors
Despite these partly antithetic functions, the TNF receptors share a common topol-
ogy causal for their way of interacting with their respective ligands. The great
majority of these receptors can be categorised as type I transmembrane proteins,
exhibiting an extracellular N terminus with a signal peptide and an intracellular
C terminus [68]. Some members, however, differ from this rule as they possess no
signal peptide (e.g. B cell Activating Factor Receptor, BAFFR, B Cell Maturation
Antigen, BCMA and X-linked Ectodysplasin-A2 Receptor, XEDAR), only exist as
soluble forms (Osteoprotegerin, OPG and Decoy Receptor 3, DcR3) or reveal an-
other mechanism for anchoring in the membrane (TNF-Related Apoptosis-Inducing
Ligand Receptor 3, TRAIL-R3) [68]. Several of the transmembrane receptors also
occur as soluble forms after being proteolytically cleaved from the cell surface (e.g.
Tumour Necrosis Factor Receptor 1 and 2 (TNF-R1 and TNF-R2), CD27, CD30
and CD40) or by removal of the transmembrane region via alternative splicing (e.g.
4-1BB) [69, 70]. These soluble variants are probably able to regulate the activity of
their designated ligands [68].
The extracellular domain of the receptors is characterised by Cysteine Rich Do-
mains (CRD), which typically consist of six cysteine residues forming a distinct
repetitive pattern [71]. The disulphide bonds, formed by these cysteines, generate
a topological framework, which is supplemented by a varying number of additional
amino acids. This diversity within the CRD sequences allows for specific interac-
tions with their destined ligands [72]. According to the number of cysteines and the
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topology of disulphide bridges, the CRD can be further categorised into different
submodules: the letters describe the fold of the subunits and the digits indicate the
number of disulphide bridges [73]. The combination of submodules within the CRD
varies among different receptor molecules.
At first, five submodules, namely A1, A2, B1, B2 and C2 were established by
Naismith and Sprang [73], but with the ongoing characterisation of structural prop-
erties, new subunits D2, X2 and N were added to the existing modules [68, 74]. As
the search for additional family members and the investigation of already known
members still proceeds and yields even improved structural models, new subunits
may be introduced [75].
The number of CRD in the ectodomain varies between the different members of
the receptor family, ranging from only an incomplete CRD in the BAFFR, three
complete and one truncated CRD in the OX40 receptor to six CRD in the CD30
molecule [76]. Due to these CRD, the extracellular domain of the receptors possesses
a stretched shape, which is important for ligand binding [77]. Figure 4 illustrates the
typical structure of a TNF receptor family member using the example of chicken
OX40. Additionally, the N-terminal region of several receptors (e.g. TNF-R1,
TNF-R2 and CD40) was reported to contain a so-called Pre-Ligand-binding Assem-
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Figure 4: The structure of TNFRSF members.
A, The model of chicken OX40 receptor trimer illustrates the characteristic feature
of the extracellular domain of the members of the TNFRSF. Each OX40 monomer
exhibits four CRD, represented by red hexagons. CRD1, 2 and 4 are composed
of two subunits (indicated in brackets, in the colour scheme of (B)), whereas the
CRD3 solely consists of one subunit. B, The amino acid sequence of chicken OX40
extracellular domain displays the CRD1-4 as indicated, following the analysis of
human OX40 by Willoughby et al. [78]. The residues forming the different subunits
(A1, B1, B2) are coloured: A1 green, B1 blue, B2 grey. The cysteine residues and
the disulphide bridges (S-S) are marked in red. The dots indicate the C-terminal
sequence of the OX40 stalk region, its transmembrane and intracellular domain.
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bly Domain (PLAD) [79]. It enables the preassembling of the receptor molecules
on the cell surface prior to the interaction with their respective ligands [79]. The
functional implications of receptor preassembly are specified in section 2.4.
2.2.2 Functional classification of TNFRSF members
The cytoplasmic region and the intracellular signalling pathway allow for the func-
tional classification of TNFRSF members into three groups [80].
Decoy receptors lack an operative intracellular domain and are thus thought to re-
strain interaction with functional receptors (e.g. DcR3 for Fas Ligand, FasL) [81].
Besides the typical decoy receptors (DcR3, OPG, TRAIL-R3 and TNF-Related
Apoptosis-Inducing Ligand Receptor 4, TRAIL-R4), also the soluble variants of
TNFRSF, originating from proteolytic cleavage, can act as decoy receptors [82].
A second group of receptors exhibits an intracellular, so called Death Domain (DD)
promoting apoptosis upon interaction with the respective ligands. Examples for
DD containing receptors are Fas, Death Receptor 3 (DR3) or TNF-R1, which can
mobilise caspase cascades causing changes in the nucleus, membranes and cytoskele-
ton, which are typical of apoptosis [67].
As a third group, receptors like TNF-R2, OX40 or 4-1BB comprise an intracellular
motif allowing for the interaction with TNF Receptor-Associated Factors (TRAF)
[83]. These adaptor molecules are part of an intracellular signalling pathway primar-
ily promoting cell activation, differentiation and survival. This signalling cascade
will be further described in section 2.5 using the example of the OX40 molecule.
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2.3 The tumour necrosis factor superfamily
The eponym of this ligand family, TNFα, was first described in the 1960ies as
a factor, which was produced upon endotoxin treatment in mice and which was
able to induce apoptosis of tumour cells [84]. Since then, the number of identified
molecules, which were related to TNFα, steadily increased. Due to the structural
homologies to their most prominent member, a number of 19 cytokines [82] are
classified as the tumour necrosis factor superfamily in humans. Forming functional
systems with their respective receptors, TNFSF members are involved in a wide
variety of processes. They participate in the formation and regulation of various
tissues, like the neuronal and lymphoid systems, the skin or the mammary gland
[76]. In addition, they contribute to the generation and elimination of immune
responses upon antigen encounter.
2.3.1 The structure of tumour necrosis factor ligands
Like the superfamily of receptors, TNF ligands share a certain homology of about
15-20% and, more importantly, a common topology, which impacts their function-
ality [85]. The TNFSF members are type II transmembrane proteins with an in-
tracellular N terminus and a C-terminal extracellular region with a TNF Homology
Domain (THD) [76]. The THD sequence comprises a conserved scaffold of aromatic
and hydrophobic amino acids, which allows for non-covalent trimerisation of three
THD domains forming a condensed, bell-like molecule (Figure 5A and B) [86]. As
illustrated in Figure 5C, for the TNFα molecule, a THD exhibits a so called jelly
roll topology. It is composed of two β-sheets, which form an antiparallel β-sandwich.
Each sheet, in turn, consists of five antiparallel β-strands (indicated with letters)
[86]. The inner sheet establishes contact to the other two THD protomers, while
the outer sheet constitutes the exterior of the trimeric protein [86]. Consequently,
each ligand homotrimer possesses three receptor-binding sites located in a groove,
which is formed by two adjoining THD [76].
Numerous ligands exert their functions as membrane-bound molecules. Neverthe-
less, several TNFSF members occur as soluble variants, after being cleaved from
the cell surface by different proteases [68]. Obviously, solubilisation of these ligands
can alter their impact compared to the effects performed by their cell-bound forms.
On the one hand, solubilisation can be necessary to expand their range of action,
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as it is reported for the ligand Ectodysplasin A (EDA) [87, 88]. On the other hand,
cleavage from the cell surface can also diminish their effectiveness, as e.g. apoptotic
effects of soluble FasL are reported to be reduced compared to its surface-bound
form [89].
B	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Figure 5: The structure of TNFSF members.
A, The model of an OX40L trimer illustrates the characteristic bell shape of TNF
ligands. B, The top view of the crystal structure of mouse OX40L trimer. C, Model
of the jelly roll topology of the TNFα molecule illustrating the basic structure of the
THD in TNF ligands [86]. The THD consists of two antiparallel β-sheets, which are
divided by the dashed line in the diagram (the inner sheet on the left, the external
sheet on the right). Each β-sheet, in turn, comprises five β-strands (labelled a-h ac-
cording to their sequential arrangement within the primary sequence); a’ and b’ are
loops of the b strand. They form short strands, which adjoin the strands a and b.
B: The Crystal Structure of the Costimulatory OX40-OX40L Complex [90], item
2HEW from RCSB PDB [91, 92], created with NGL viewer [93, 94], style: cartoon.
C: Reproduced from: The structure of tumor necrosis factor-alpha at 2.6 A resolu-
tion. Implications for receptor binding [86].
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2.3.2 Classification of TNFSF members according to their structural
properties
Although TNF ligands generally share the formation of homotrimers exhibiting a
bell-like shape, they can be classified into three categories according to their struc-
tural properties: the conventional, the EF-disulphide and the divergent group [90].
The conventional group of ligands comprises e.g. the molecules CD40 Ligand
(CD40L), FasL and TNFα, and is well defined, as crystal structures were gener-
ated for several of its members [86, 95]. Analyses revealed that this conventional
group exhibits elongated loops between the antiparallel β-strands CD, DF and DE,
which are responsible for its typical pyramidal conformation. Moreover, members
of this group share a conserved hydrophobic residue within the DE loop, arguing
for a conserved way of receptor interaction [90].
The members of the EF-disulphide group, e.g. B cell Activating Factor belonging to
the TNF Family (BAFF) and EDA, were likewise characterised via crystallography
[96, 97]. The analyses exhibited the eponymous disulphide bond between strands E
and F as their distinctive feature [90]. In addition, crystal structures revealed the
absence of the hydrophobic residue, which is pivotal for receptor interaction and
conserved within the conventional group. Furthermore, the structures displayed
shortened CD and EF loops causing a more spheroidal conformation [90].
The third group with its members OX40L, 4-1BBL, CD27L, CD30L and GITRL,
was denominated divergent group as the amino acid sequences show only low ho-
mology within the subgroup, but also to the other two subgroups [90]. The molecule
OX40L is a typical representative of the divergent group as it shares only 10-15%
sequence identity with other TNFSF members [90].
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2.4 Receptor-ligand interactions
In general, TNFSF members form homotrimers and are reported to interact with
their respective receptors in a 3:3 ratio, as depicted in Figure 6 for OX40 and OX40L.
Three elongated receptor molecules bind in parallel in the three grooves of the ligand
homotrimer, each formed by two ligand protomers [72]. This was first demonstrated
for the ligand TNFβ and its receptor TNF-R1 by Banner et al. in 1993 [77] and con-
firmed for other members of the TNF superfamily, e.g. for OX40L and its receptor
OX40 [90]. Even though molecular domains of receptors and ligands, which partic-
ipate in the mutual interaction, vary among the different receptor-ligand pairs, the
3:3 concept of receptor-ligand interaction seems to be conserved within the TNF su-
perfamily [68]. The involvement of varying molecular regions in the binding between
different receptors and their cognate ligands gives rise to the specificity of these in-
teractions [68]. Probably due to this specific recognition process, some TNF family
members were reported to solely bind one partner in mammals, for instance OX40
and OX40L, GITR and GITRL or CD30 and CD30L [98]. Nevertheless, several
ligands are known to interact with different receptors, thus rendering the impacts
of the TNF superfamily more complex and flexible [72, 98]. Irrespective of the na-
ture of the interacting receptor-ligand pair, Vanamee and Faustmann [82] suggest
a model explaining the condition prior to the process of mutual binding. It further
describes the mechanism of interaction itself and its correlation with intracellular
A	   B	  
Figure 6: The 3:3 interaction between OX40 and OX40L monomers.
A, The side view of the crystal structure of human OX40 trimer (red) bound to
human OX40L trimer (blue). B, Crystal structure of the human OX40-OX40L-
complex viewed from the membrane of the ligand-expressing cell.
A and B: The Crystal Structure of the Costimulatory OX40-OX40L Complex [90],
item 2HEV from RCSB PDB [91, 92], created with NGL viewer [93, 94], style:
A: spacefill, B: cartoon.
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signalling. Due to the PLAD domain within the N terminus of TNF receptors,
free receptor monomers can form dimers [79, 99]. These dimers were found in a
parallel or an antiparallel orientation [100], as illustrated in Figure 7A. Within par-
allel receptor dimers, sites for ligand-interaction are uncovered, because monomers
are collocated in a back-to-back manner [82, 100]. In contrast, antiparallel dimers,
formed by CRD1 and CRD2, hide fractions of the ligand-binding site. The con-
formation of the antiparallel molecules prevents interactions with the ligand and
thus represents the passive state of the receptors [82, 100]. Both potential receptor
dimers are assumed to organise as a hexagonal mesh on the cell surface (Fig. 7B).
Three receptor monomers adjoin at the junctions of the hexagons to form ligand-
binding sites preserving the 3:3 stoichiometry. A receptor dimer is composed of two
receptor monomers from two collocated ligand-binding sites [82]. The preassembly
of receptor molecules is necessary for subsequent ligand interaction and efficient
intracellular signalling [101]. It facilitates the formation of a hexagonal network of
the associated intracellular signalling proteins [102]. Since the model of antiparallel
receptor dimers better agrees with the configuration of cytoplasmic signalling com-
ponents, this mode of dimerisation is more likely to reflect the actual state before
ligand interaction (Fig. 7C) [82]. Upon ligand binding, antiparallel receptor dimers
dissolve. The monomers undergo a conformational change to orientate perpendic-
ularly to the cell membrane, transmitting intracellular signals and yet preserving
the hexagonal geometry. In this process, the transmembrane regions of receptors
likewise trimerise and allow for the merging of the intracellular domains [82]. This,
in turn, ensures their interaction with the network of hexagonally organised adaptor
proteins of the signalling cascade [103].
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Figure 7: A model of receptor preassembly and receptor-ligand interac-
tion.
A, The two possible modes of receptor (light red) dimerisation (parallel and an-
tiparallel) on the cell surface prior to ligand encounter. While parallel receptor
dimers expose their ligand-binding sites, the latter are hidden in antiparallel dimers.
B, Both types of receptor dimers can form hexagonal networks on the cell surface,
which is illustrated for antiparallel receptors. C, Prior to ligand binding, the recep-
tors (light red) preassemble as antiparallel dimers, forming a hexagonal network on
the cell surface. Upon contact with the ligand (blue), receptor dimers abandon their
resting state and undergo conformational changes. These changes within the recep-
tor molecules allow for ligand binding in a 3:3 stoichiometry and enable subsequent
signalling events [82].
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2.5 Signalling pathways
OX40 and other members of the TNF receptor family, which are involved in the pro-
cess of T cell costimulation, belong to the TRAF-interacting receptors. Thus, the
OX40 molecule constitutes an excellent example of a costimulatory receptor sustain-
ing T cell activation. The signalling pathways underlying its costimulatory effects
in T cells and the phenomenon of reverse signalling within the ligand-expressing
cells will be described in the following sections.
2.5.1 Signalling cascade of OX40 within the T cell
OX40 molecules are not constitutively expressed on T cells, but they are upregulated
after the TCR was triggered. Therefore, it is difficult to examine the OX40 down-
stream pathways and their effects irrespectively of effects caused by TCR signalling
itself [78]. Most studies hence delineate the effects of OX40 signalling following TCR
stimulation and indicate its contributions to the generation of the T cell response.
Figure 8 summarises the main components of OX40 signalling. After binding of
OX40L to its receptor OX40, different signalling cascades within the T cell have
been described, which allow for clonal expansion, longevity and cytokine produc-
tion. The intracellular domain of OX40 molecules exhibits a QEE motif [104], which
permits the interaction with TRAF as major mediators in downstream signalling
events [105]. To date, six different TRAF are characterised in mammals [83]. Differ-
ent TNF receptors use a diverse set of these adaptor proteins for signalling, where
TRAF2 seems to be an essential component for all costimulatory molecules [106].
TRAF1-3, 5 and 6 were reported to mediate signal transduction within the OX40-
OX40L system in vivo [82, 107, 108]. TRAF2 and 5 adaptor molecules induce
the Nuclear Factor κ-light-chain-enhancer of activated B cells (NF-κB) pathway,
whereas TRAF3 probably restrains this signalling cascade [108].
Via both the canonical NF-κB1 and the non-canonical NF-κB2 pathway, OX40 sig-
nalling stimulates the expression of anti-apoptotic proteins and survival factors like
B cell lymphoma 2 (Bcl-2), Bcl-xL and Bcl2-related protein A1 (BCL2A1) [63, 109,
110].
Furthermore, OX40 costimulation was reported to support the signalling cascades
mediated by the TCR, primarily by sustaining the activation of Phosphatidylinosi-
tol 3-Kinase (PI3-K) and Protein Kinase B (PKB) and other intermediates involved
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in this pathway: via increased expression of survivin, combined TCR and OX40 sig-
nals enable the cell cycle progression from G1 to S phase, thus promoting T cell
mitosis [111, 112].
Moreover, OX40 and TCR signals cooperate in activating Nuclear Factor of Acti-
vated T cells (NFAT), which allows for the production of cytokines like IL-2, IL-4
and IL-5, depending on the existing cell polarisation. The evolving cytokine milieu
thereby causes the subsequent differentiation into different T cell effector subsets
and their maintenance [113, 114].
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Figure 8: Signalling pathways of OX40 upon OX40L interaction.
Upon interaction with OX40L on APC, the cytoplasmic domains of OX40 molecules
interact with the TRAF adaptor proteins to transduce signals via three main path-
ways. Activation of the NFκB pathway primarily results in the generation of anti-
apoptotic signals, whereas activation of PI3-K and PKB mainly drives cell division.
The activation of the NFAT pathway promotes cytokine production, which in turn
supports cell proliferation and differentiation.
36
2.5.2 Reverse signalling
As reflected in the remarks above, most studies investigating the cytoplasmic pro-
cesses of OX40-OX40L system, dealt with the signalling events in the OX40-ex-
pressing cells and their functional implications for the T cell response. By now, it
is well established that upon OX40-OX40L interaction, the intracellular signalling
is not restricted to the receptor-bearing cell, but can also be observed within the
OX40L-expressing cells [115, 116]. This bidirectional communication, also called
reverse signalling, is reported for different members of the TNF superfamily like
TNFα, OX40L, CD30L, CD40L, and FasL [117, 118].
Detailed information of intracellular signalling pathways of the TNFSF members
is not yet available, but the structural properties of the intracellular domains of
TNF ligands suggest certain mechanisms. Homology analyses of the cytoplasmic
domains of different TNF ligands revealed only poor levels of identity, arguing for
the utilisation of diverse signalling pathways instead of a conserved cascade within
the superfamily [119]. Additionally, the cytoplasmic regions of these ligands exhibit
no enzymatic functions, which indicates that cytoplasmic signals are delivered via
adaptor proteins [117]. However, the latter still have to be identified and charac-
terised.
Even though the mechanism of reverse signalling, its intracellular components and
their interaction need to be further investigated, the diverse effects of bidirectional
signalling of different TNFSF members have already been described [117] and are
summarised in the following, for OX40L-bearing cells in section 2.6.3.
In general, the phenomenon of reverse signalling allows for adjusting and shaping
an ongoing immune response. Both cells, expressing receptor or ligand, mutually
impact their functions upon cell-to-cell contact, rendering the system more complex
and also significantly more tunable [117].
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2.6 The OX40-OX40L costimulatory system
The OX40 receptor, also referred to as TNFRSF member 4 (TNFRSF4), CD134 or
ACT35 [120] was identified in 1987 by an antibody called MRC Ox-40, recognising a
molecule on activated CD4+ cells in rats [121]. Its ligand OX40L (TNFSF4, CD252,
glycoprotein 34, gp34) [122] was already described in 1985 as the protein gp34,
which was expressed by a T cell line derived from transformation with human T cell
leukemia virus type-I [123]. Baum et al. [124] finally identified the former gp34
molecule as OX40L. OX40 and OX40L notably impact the generation of an effective
immune response upon antigen encounter. Their prominent and far-reaching role
in host defence is reflected by their widespread expression profile.
2.6.1 Expression profile of OX40
In human and mouse, näıve T cells lack the expression of OX40, but they upregulate
the receptor twelve hours up to five to six days after antigen encounter and TCR
triggering [63, 115, 125]. The following activated T cell subsets express OX40 on
their cell surface: CD4+ T cells [125, 126], CD8+ T cells [127], as well as Treg and
different T helper subpopulations (Th1, Th2, Th9 and Th17 cells) [110, 115, 128].
Effector and probably also memory T cells with former contact to an antigen, can
quickly upregulate the molecule upon secondary antigen encounter [114]. In vivo,
activated T cells bearing OX40 can be detected in the paracortex of lymph nodes
and in the periarteriolar lymphoid sheaths of the spleen upon immunisation with
protein antigen [129, 130]. Moreover, OX40-expressing T cells were visualised upon
inflammation during several diseases, e.g. during tumour growth [131], Graft versus
Host Disease (GvHD) [132, 133] or during immunologically associated diseases of
the gastrointestinal tract [134]. Additionally, OX40 was detected on neutrophils
[135], NK cells [136] and Natural Killer T (NKT) cells [137] at lower densities.
Different parameters such as the type of antigen, its persistence, the involved T cell
population and the emerging cytokine milieu affect the level and the period of
OX40 expression [138]. Furthermore, cytokines like TNFα, IL-1 and IL-4 as well
as signalling through other secondary costimulatory molecules as IL-2R and CD28,
favour an optimal and sustained expression of OX40 [115, 128].
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2.6.2 Expression profile of OX40L
The expression of the OX40L molecule in humans and mice is primarily associ-
ated with different types of APC, namely Dendritic Cells (DC) [139], B cells [140],
macrophages [141] and Langerhans cells [142]. Upregulation of the ligand is stim-
ulated by different factors like signalling via the B cell receptor, Toll-like receptors
or the CD40 molecule and accordingly by soluble factors as IL-18, Thymic Stromal
Lymphopoietin (TSLP), IFNγ or prostaglandin E2 [115, 143–146]. Besides its ex-
pression on APC, OX40L was also detected on a broader range of cell types, e.g. on
mast cells [147, 148], NK cells [149], on smooth muscle cells [150] and on endothelial
cells [151]. In addition, activated CD4+ and CD8+ cells were reported to express
OX40L, arguing for an alternative way to sustain T cell responses via T cell-T cell
interactions in addition to APC contact [152].
OX40L expression was also detected in association with various diseases, e.g. during
chronic infections [153] or at inflammatory sites during autoimmune reactions [154].
2.6.3 Functions of the OX40-OX40L system during an immune response
Among the costimulatory TNFRSF members involved in the activation process
of T cells, the OX40-OX40L system is regarded as a key mediator ensuring the
longevity of a T cell response by enhancing the proliferation of diverse T cell sub-
sets upon different stimuli [155]. However, the activating and proliferating effects of
the OX40-OX40L system only become operative in later activation stages, following
initial activation signals via the CD28-B7 system [63].
OX40 and OX40L knockout mice, as well as agonistic and antagonistic antibodies
assisted to investigate the impacts of the OX40-OX40L system in mammals. The
receptor-ligand pair was first demonstrated to support primary and secondary CD4+
T cell responses as well as the development of immunological memory [114, 130, 156].
As described in section 2.5, OX40 triggering mediates several anti-apoptotic signals
and thereby notably adds to the proliferation and survival of T cell populations.
The costimulatory effects of OX40 signalling in the T cell are summarised in Fig-
ure 9. To preserve the activation state, OX40 signalling induces the upregulation of
IL-2Rα chain [157] and the production of IL-2 as an autocrine stimulus [114]. It fur-
ther promotes the expression of the OX40L molecule on activated T cells to provide
costimulatory signals to other T cells for maintaining the activation state indepen-
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dently of APC involvement [116, 152, 158]. Besides, experiments report that OX40
costimulation also adds to the adhesion of T cells to OX40L-expressing endothelial
cells and that it is involved in T cell migration to germinal centres and to inflamma-
tory sites by the upregulation of molecules like C-X-C motif chemokine Receptor 5
(CXCR5) on T cells [65, 159]. Depending on the prevailing cytokine environment,
OX40 signalling promotes the expansion of different T helper cell subsets (Th1,
Th2, Th9 and Th17) and supports the production of their associated cytokines
[110, 138, 160]. Equally, the existing cytokine milieu, together with the distribution
of OX40 molecules on different T cell subsets and its extent of expression, deter-
mines the course of the T cell response and the preservation of homeostasis. On the
one hand, under the influence of IL-4 and IFNγ, OX40 binding promotes an effector
phenotype of CD4+ cells, which is less susceptible to Treg-mediated suppression
[161]. This implies the upregulation of surface molecules like IL-12Rβ2 receptor
chain [162] and the downregulation of regulatory elements such as Transforming
Growth Factor β (TGF-β), Forkhead box protein P3 (FoxP3) [163], IL-10 [164] and
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Figure 9: Effects of OX40 signals for T cells.
OX40 signalling on T cells adds to the expression of IL-2R, IL-12R and OX40L, as
well as of CXCR5. It further promotes cytokine production and survival signals,
thus favouring the effector phenotype (positive effects indicated by arrows). By
inhibiting the expression of FoxP3, CTLA-4, TGF-β and IL-10 (indicated by barred
lines), it restrains the differentiation into a regulatory phenotype.
40
Cytotoxic T Lymphocyte-Associated protein 4 (CTLA-4) [165].
On the other hand, signals by the costimulatory receptor OX40 are necessary to as-
sure the abatement of the immune response and the restoration of the original state.
As Takeda et al. demonstrated [161], OX40 also plays a role in the development and
proliferation of Treg, as their number is diminished in OX40 knockout animals and
increases in animals, which constitutively express OX40L. In addition, signals via
this TNFRSF member account for a fully effective decimation of superplus effector
cells by Treg [161]. Analogous to its effects on CD4+ T cells, OX40 signalling also
ensures the expansion, the longevity and the memory generation of CD8+ T cells
[127, 166–168]. Furthermore, it is reported to support the activity of NK and NKT
cells and their secretion of IFNγ, thus further boosting T cell activation upon anti-
gen encounter [136, 137]. Besides professional APC, other cell types like endothelial
and muscle cells as well as mast cells are able to provide the OX40L molecule at the
sites of infection and inflammation to activated T cells expressing OX40 in order to
sustain and further increase the T cell response [115].
With binding of OX40 to OX40L, not only T cells receive costimulatory signals via
the OX40 molecule, but also the OX40L-expressing cells seem to activate intracel-
lular cascades altering their metabolism, cytokine production and differentiation by
reverse signalling [115]. Even though this process of bidirectional interaction be-
tween OX40 and its ligand remains to be further investigated, different studies hint
at its important role in preparing a local proinflammatory milieu to additionally
strengthen the host defence [115]. The impacts of OX40-OX40L interactions on
OX40L-expressing cells are illustrated in Figure 10.
In dendritic cells, OX40L signalling was reported to assist their activation and mat-
uration, which is represented by the upregulation of CD83. Furthermore, signals via
OX40L stimulate cytokine production (TNFα, IL-1β, IL-6 and IL-12) and support
the upregulation of costimulatory molecules such as CD40, CD54, CD80 and CD86
[169].
OX40L binding on B cells promotes their differentiation into plasma cells and aug-
ments the level of secreted antibodies, adding to the crucial effects of CD40-CD40L
interactions [129, 170].
As already mentioned above, the interaction between OX40L-expressing endothelia
and OX40-bearing T cells supports the increased adhesion of T cells to the en-
dothelial cells and their subsequent transmigration. On the side of T cells, this
OX40-OX40L interaction induces the migration-associated molecule CXCR5. By
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Figure 10: Effects of reverse signalling via OX40L for OX40L-expressing
cells.
A, OX40L binding on DC promotes their differentiation and maturation, which is
represented by the upregulation of the CD83 molecule. Additionally, it augments the
production of IL-1β, IL-6, IL-12 and TNFα, as well as the expression of costimulatory
molecules like CD40, CD54, CD80 and CD86. B, In B cells, reverse signalling via
OX40L promotes their differentiation into plasma cells and increases the production
of antibodies. C, Endothelial cells express CCL5 upon OX40L signals, thereby
promoting the transmigration of activated T cells. D, OX40L signals inhibit the
degranulation of mast cells.
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reverse signalling through the OX40L protein, endothelial cells also facilitate the
migration of T cells to germinal centres by upregulating the C-C chemokine Ligand
5 (CCL5), also known as RANTES (Regulated on Activation Normal T cell Ex-
pressed and Secreted) [171].
Mast cells expressing OX40L were also reported to assist T cell activation and
proliferation [147, 148]. Moreover, they have a great impact on both effector and
regulatory T cell pools, restraining the suppression of Treg in autoimmune diseases
[172]. However, bone marrow-derived mast cells constitutively expressing OX40L
can also be affected by bidirectional signalling through OX40L upon binding of
OX40 on Treg. As demonstrated by Piconese et al. [172] and Gri et al. [173],
signalling through the TNF ligand resulted in a decreased histamine degranulation
mediated by the high affinity Immunoglobulin E receptor. This finding suggests
a prominent role of the OX40-OX40L system in the direct regulation of the acute
phase during allergy via mast cell-Treg interactions.
In summary, the occurrence of reverse signalling within the OX40-OX40L system
highlights its involvement during host defence and emphasises its crucial impact in
the formation of an immune response.
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3 Objective
Within the TNF superfamily of costimulatory molecules, which are involved in
T cell activation, OX40 and its ligand OX40L are reported to be indispensable for
the longevity of the evolving T cell response. In mammals, the OX40-OX40L sys-
tem adopts a pivotal role by providing survival signals as well as by promoting cell
proliferation, differentiation and cytokine production. However in chickens, infor-
mation on the process of T cell costimulation remains scarce.
The aim of this study was to characterise the chicken homologues of mammalian
OX40 and OX40L and to confirm their involvement in the process of chicken T cell
activation.
The characterisation comprised three consecutive steps. The genomic identification
and correct attribution of the chicken molecules OX40 and OX40L was a prerequi-
site to analyse their phylogenetic and structural relation to their mammalian homo-
logues. As a second step, cloning and recombinant expression of soluble and cell-
bound variants allowed for the investigation of additional properties of the chicken
molecules, such as their ability of mutual interaction and the tendency of the soluble
forms to dimerise. In the third part of the study, we demonstrated the involvement
of the OX40-OX40L system in chicken T cell activation by proving the existence of
OX40L on activated chicken αβ and γδ T cells. The recombinant variants of chicken
OX40 and OX40L, which were generated within this study, may serve as tools for
further studies of chicken T cell activation.
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The Tumour Necrosis Factor superfamilies of receptors and ligands play a crucial role in the regulation of
effective immune responses against pathogens and malignant cells. In chickens, only few members have
been identified. Here, we characterise the chicken homologues for mammalian costimulatory molecules
OX40 and OX40L, which are involved in sustaining T cell responses. Both genes were identified by virtue
of their genomic localisation close to highly conserved genes and their structural relationship to their
mammalian homologues. Following cloning and expression of soluble and cell-associated chicken OX40
and OX40L, we confirmed their mutual interaction via ELISA and flow cytometric analyses. In addition,
we showed the application of soluble OX40-Fc in staining of chicken cells. Whereas non-activated cells
did not express OX40L, activation by IL-2 and IL-12 resulted in upregulation of OX40L on ab and gd T cell
populations. Our results demonstrate the existence of the costimulatory OX40-OX40L system in the
chicken and provide the basis for further investigations of chicken T cell responses.
© 2018 Elsevier Ltd. All rights reserved.
1. Introduction
T cell activation is a complex process involving various forms of
signals and receptors. Besides TCR triggering, binding of cos-
timulatorymolecules is pivotal to obtain a complete activation state
in terms of cell differentiation, proliferation, longevity and cytokine
production.
The classic costimulatory receptors belong to three superfam-
ilies: the Immunoglobulin (Ig) superfamily (e.g. CD28 or CD2), the
family of cytokine receptors (e.g. IL-2R or IL-7R) and the Tumour
Necrosis Factor Receptor Superfamily (Croft, 2003). In the past
decades, the focus of research of the T cell activation process was
dominated by the investigation of CD28 signals. Only more recently
the Tumour Necrosis Factor (TNF) superfamily, comprising re-
ceptors (TNFRSF) and their respective ligands (Tumour Necrosis
Factor Superfamily, TNFSF), was studied more intensively (Croft,
2003). The family of TNFRSF receptors comprises 30 members
(Gaur and Aggarwal, 2003), which can be divided into three func-
tional groups depending on their intracellular signalling pathways
(Ward-Kavanagh et al., 2016): so called decoy receptors without a
cytoplasmic domain are distinguished from receptors containing a
death domain (DD) in their cytoplasmic region which induces
apoptosis. The third group comprises family members, which
contain an intracellular motif for binding to adaptor molecules of
the signalling cascade, called TRAFs (TNF Receptor-Associated
Factors), promoting activation, survival and differentiation.
Several TNF family members play major roles in sustaining T cell
activation subsequent to the primary costimulatory effect of the
CD28-B7 system. Among these receptors (CD27, CD30, GITR, 4-1BB,
HVEM) (Watts, 2005), OX40 (CD134) and its ligand OX40L (CD252)
hold a prominent position, as they ensure the longevity of T cell
response by supplying anti-apoptotic signals (Rogers et al., 2001).
During an immune response, the OX40-OX40L system regulates the
functions of CD4þ and CD8þ T cells, regulatory T cells, Natural Killer
(NK) and Natural Killer T (NKT) cells and interacts with Antigen
Presenting cells (APCs) and tissue cells like endothelial or smooth
muscle cells (Croft, 2010).
The receptor OX40 is a TRAF binding receptor and is reported to
be a key mediator of costimulatory signals in mammalian T cells
(Croft, 2010). OX40 belongs to the group of type I transmembrane
proteins exhibiting an extracellular N terminus and an intracellular
C terminus (Bodmer et al., 2002). Its extracellular domain com-
prises four Cysteine-Rich Domains (CRDs) which are the charac-
teristic feature of TNFRSF receptors, but whose number may differ
between family members (Ware, 2003). Due to these cysteine
residues, the ectodomain of OX40 exhibits a stretched shape which
allows for ligand binding (Banner et al., 1993).
Abbreviations: TNF, Tumour Necrosis Factor; TNFRSF, Tumour Necrosis Factor
Receptor Superfamily; TNFSF, Tumour Necrosis Factor Superfamily.
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In mouse and human, the OX40 molecule is absent on naïve T
cells, but is upregulated during the activation process as early as
12 h up to 5e6 days after antigen contact and TCR stimulation
(Croft, 2010; Latza et al., 1994; Rogers et al., 2001). It can be
detected on activated CD4þ (Latza et al., 1994; Mallett et al., 1990)
and on CD8þ T cells (Bansal-Pakala et al., 2004), as well as on Th1,
Th2, Th17 subsets of T helper cells and on regulatory T cells (Croft,
2010; Redmond et al., 2009). In addition, NK cells (Liu et al., 2008),
NKT cells (Zaini et al., 2007) and neutrophils (Baumann et al., 2004)
express the receptor at lower densities. The time course of OX40
expression depends on different factors like the nature of the an-
tigen, its persistence, the evolving proinflammatory milieu and the
affected T cell subset (Rogers and Croft, 2000). The involvement of
other costimulatory molecules such as CD28, IL-2R or the presence
of cytokines like IL-1, IL-4 and TNF also contributes to an optimal
and prolonged expression (Croft, 2010; Redmond et al., 2009).
OX40L, like the other ligands of this family, is a type II trans-
membrane protein which exhibits an intracellular N terminus and
an extracellular C terminus with a TNF Homology Domain (THD)
(Ware, 2003). The THD is formed by two antiparallel b sheets which
rejoin with the respective THDs of two other protomers to form
non-covalent homotrimers. To date, the OX40 receptor is known
only to bind its ligand OX40L (Croft, 2010) while other members of
the TNFRSF family can interact with different ligands (Idriss and
Naismith, 2000). As reported for other ligands like TNF, BAFF or
FasL, OX40L also exists as a soluble variant, cleaved from the cell
surface probably after the interactionwith its receptor (Croft, 2010).
Human and murine OX40L molecules are expressed by a
broader range of cell types, particularly on different kinds of acti-
vated APCs comprising B cells (Linton et al., 2003), macrophages
(Karulf et al., 2010), dendritic cells (Jenkins et al., 2007) and Lang-
erhans cells (Sato et al., 2002). OX40L expression is promoted by
various stimuli like signalling through Toll-like receptors, the B cell
receptor and the CD40 molecule or the presence of IL-18, TSLP
(Thymic Stromal Lymphopoietin), IFNg or prostaglandin E2 (Croft,
2010; Ito et al., 2005; Krause et al., 2009; Kurche et al., 2012;
Maxwell et al., 2006). Furthermore, OX40L was observed on acti-
vated CD4þ and CD8þ T cells, suggesting an additional way of
sustaining T cell response via T cell-T cell interactions (Mendel and
Shevach, 2006). The expression of OX40 and OX40L in such a wide
range of cell types affirms the manifold and extensive influence of
the OX40-OX40L costimulatory system in mammals.
In chickens and other birds, information about representatives
of the TNF superfamily, particularly about OX40 and OX40L, re-
mains scarce. Although the genomic location of several members of
the TNF superfamily has already been identified, the trace of others
remains obscure, partly due to the incomplete annotation of the
chicken genome (Kaiser, 2012). To date, chicken CD30 (Burgess
et al., 2004) and CD30L (Abdalla et al., 2004) are the only TNF
members involved in T cell activation, which were characterised in
chickens. In our study, we describe the molecular cloning and
expression of the chicken TNF receptor-ligand pair OX40-OX40L,
characterise their structural properties, their ability of mutual
recognition and their possible application in the cell staining of
primary chicken cells. As OX40 and OX40L represent key cos-
timulatory molecules in the activation process of T cells, our results
will advance the understanding of the T cell response in chickens.
2. Materials and methods
2.1. Animals
Chicken line M11 was kindly provided by S. Weigend (Federal
Research Institute for Animal Health, Mariensee, Germany). Fertil-
ised eggs were incubated and hatched at the Institute for Animal
Physiology, University of Munich, Germany. The chickens were
reared under conventional conditions and they were eight weeks
old when experiments were performed.
2.2. Cell culture and cell preparations
Human Embryonic Kidney cells (HEK) 293 were cultured in
Roswell Park Memorial Institute (RPMI) 1640 medium (Invitrogen
life technologies, Carlsbad, CA, USA) containing 10% Fetal Bovine
Serum (FBS) (Biochrom GmbH, Berlin, Germany) in a 5% CO2
incubator at 37 C. To obtain chicken splenocytes, a single cell
suspension was prepared by passing the spleen through a stainless
steel mesh and mononuclear cells were segregated by consecutive
density centrifugation on Biocoll Separating Solution (Biochrom
GmbH). For stimulation, chicken splenocytes were plated at a
density of 106 cells per well in a 96-well flat bottom plate and
maintained at 40 C and 5% CO2 in RPMI 1640 medium supple-
mented with 10% FBS, 1% Penicillin/Streptomycin (Biochrom
GmbH) and a combination of recombinant chicken IL-2 and IL-12.
Chicken cytokines were obtained as previously described (Fenzl
et al., 2017). Every second day, cultures were diluted by the sub-
stitution of 50% of the volume per well for fresh stimulation
medium.
2.3. Database search and sequence analysis
ChOX40 and chOX40L were identified by keyword search using
the gene database of NCBI (https://www.ncbi.nlm.nih.gov/) and the
Ensembl database (https://www.ensembl.org/index.html). To
confirm their correct annotation, mRNA and protein sequences of
chOX40 and chOX40L were compared to their mammalian equiv-
alents in the database using the Basic Local Alignment Search Tool
(BLAST). Presumed protein sequences were structurally analysed by
SMART (smart.embl-heidelberg.de). Protein sequences were
aligned using the Clustal Omegamethod in the DNASTAR Lasergene
Software package. Phylogenetic analysis was performed using the
software MEGA5 (Tamura et al., 2011). Sequences of human, mouse
and turkey equivalents of OX40, CD30 and their ligands OX40L,
CD30L and of chicken TACI and BAFF were obtained by keyword
search in the database mentioned above. The amino acid sequences
of receptors or ligands were separately aligned by Muscle and
Maximum Likelihood trees were generated using the following
settings. For the data set of receptors, the JTT þ G substitution
model was used, whereas the sequences of ligands were analysed
via the JTT model. To account for gaps in sequence alignment, the
partial deletion option was selected and the tree was constructed
with 1000 bootstrap replicates.
2.4. Cloning procedures
The sequences of chOX40 (accession no. NM_001354724.1) and
chOX40L (accession no. XM_430147.4) were used for primer design.
All oligonucleotides were obtained from Eurofins, Ebersberg, Ger-
many. Primer sequences for the generation of the different con-
structs are displayed in Table 1. All constructs were verified by
sequencing (GATC, Konstanz, Germany). To generate soluble forms
of the ectodomains of OX40 and OX40L, either tagged by a C-ter-
minal human IgG1-Fc domain (henceforth “OX40-Fc”) or by an N-
terminal FLAG-tag (henceforth “OX40L-FLAG”), we applied the
following cloning strategy. We employed vectors derived from
variants of the pCR3 (Invitrogen life technologies) provided by P.
Schneider (University of Lausanne, Epalinges, Switzerland). They
either encoded an Ig signal peptide followed by a thrombin cleav-
age site and the human IgG1-Fc domain at 3’ (vector PS229) or a
signal peptide of Hemagglutinin of Influenza A virus (HA) and a
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FLAG epitope at 5’ (vector PS167). For both constructs, PCR primers
were designed for direct use with the Gibson Assembly® Master
Mix (New England Biolabs GmbH, Frankfurt amMain, Germany). In
brief, primers spanned the extracellular domains of OX40 or OX40L,
respectively, and also contained complementary sequences to the
50 and 30 of the corresponding cloning vectors (Table 1 underlined
sequences), hence creating overlapping ends. The sequences of
OX40 and OX40L were amplified by PCR on cDNA of concanavalin A
stimulated T cells using primers 2101 and 2102 (for OX40) and
primers 2093 and 2094 (for OX40L) and cloned via Gibson As-
sembly into their designated vectors. For the construction of full
length sequences of OX40 tagged by a c-Myc-tag (henceforth solely
“Myc-tag”), we performed two consecutive cloning steps via
Gibson Assembly. The oligonucleotide 2133 was synthesised,
encoding the HA signal peptide linked to the Myc-epitope and
containing overlaps with the designated vector arms. As first step,
the 2133 oligonucleotide was cloned into the pSBbi-GP vector,
comprising a gene for a Green Fluorescent Protein (GFP) (Kowarz
et al., 2015). The sequence of OX40 was obtained by PCR on cDNA
of concanavalin A stimulated T cells with primers 2137 and 2141,
creating overlaps with the vector arms and, as a second step, cloned
into the Myc-encoding pSBbi-GP vector. To obtain the OX40L-V5
construct, we performed a PCR with the primers 2144 and 2145
on cDNA of long-term stimulated splenocytes (IL-2 and IL-12)
yielding the OX40L sequence. Subsequently, it was cloned into
the pEF6/V5-His TOPO® vector using the pEF6/V5-His TOPO® TA
Expression Kit (Invitrogen life technologies).
2.5. Recombinant protein expression and purification
Stable HEK 293 cell lines expressing soluble forms of either
human Fc-tagged receptor or FLAG-tagged ligand were established
by transfecting cells with 0.7 mg of the respective constructs using
Metafectene® (Biontex Laboratories GmbH, Munich, Germany).
Transfected cells were subsequently selected with 0.8mg/ml G418
(Biochrom GmbH) for plasmid uptake. Supernatant of the trans-
fected cell clones was screened after seven days either by an anti-
human-IgG Sandwich ELISA or an anti-FLAG-M2 Sandwich ELISA
for the presence of fusion proteins. The OX40-Fc supernatant was
affinity-purified on Protein-G-coupled agarose (Merck KGaA,
Darmstadt, Germany), whereas an anti-FLAG® M2 Affinity Gel
(Sigma Aldrich St. Louis, MO, USA) was used to purify OX40L-FLAG.
For the generation of stable cell lines expressing the Myc-tagged
OX40 receptor (293-OX40-Myc) or the V5-tagged OX40L ligand
(293-OX40L-V5) on their cell surface, HEK 293 cells were trans-
fected with the corresponding vectors using 0.7 mg plasmid and
Metafectene®. In detail, for the OX40-Myc transfection, cells were
co-transfected with the OX40-Myc encoding SB vector (0.665 mg)
and a transposase encoding vector (0.035 mg). According to the
vectors' resistance, cells were selected with puromycin (1 mg/ml,
OX40-Myc construct) (Merck KGaA) or blasticidin (10 mg/ml,
OX40L-V5 construct) (Thermo Fisher Scientific, Waltham, MA,
USA). After ten days, cell clones were screened for their respective
tag-surface-expression by flow cytometry (FACS Canto II, Becton
Dickinson, Heidelberg, Germany).
2.6. ELISA
Wells of a Nunc Immuno™ MicroWell™ 96 well solid plate
(Sigma Aldrich) were coated overnight at 4 C with 3.9 mg/ml of
donkey anti-human IgG (H þ L) (Jackson ImmunoResearch Labo-
ratories Inc., West Grove, PA, USA). All incubation steps were per-
formed at 37 C for one hour and preceded by washing with PBS
buffer containing 0,05% Tween (PanReac AppliChem ITW Reagents,
Darmstadt, Germany) (PBS-T) according to standard procedures.
The plate was blocked with 5% skim milk (PanReac AppliChem ITW
Reagents) and afterwards incubated with chOX40-Fc (5 mg/ml). An
unrelated Fc-tagged chicken protein served as a negative control
(CD30-Fc). Subsequently, a twofold serial dilution of chOX40L-FLAG
in PBS-T was added. All titration steps were performed as tripli-
cates. Control wells contained the highest concentration of
chOX40L-FLAG. The interaction between receptor and ligand was
identified by a murine anti-FLAG® M2-HRP mab (Sigma Aldrich).
Subsequently, specifically bound mab was detected using the 3,30-
5,50-tetramethylbenzidine-substrate and absorbance was
measured at 450 nm and analysed via X-Read Plus using TECAN.
Sunrise™ (Tecan Deutschland GmbH, Crailsheim, Germany).
2.7. Western blot
Samples of chOX40-Fc and chOX40L-FLAG were prepared under
reducing (with 1M dithiothreitol) (DTT) (PanReac AppliChem ITW
Reagents) and non-reducing conditions (without DTT), separated
by a 7.5% (OX40-Fc) or a 12% (OX40L-Flag) SDS polyacrylamide gel,
and electroblotted onto a Polyvinylidene Difluoride (PVDF) mem-
brane (GE Healthcare Life Sciences, Chalfont St Giles, Buck-
inghamshire, UK). The molecular weight marker PageRuler™
Prestained Protein Ladder (Thermo Fisher Scientific) served as
protein standard. After blocking with 5% skim milk, membranes
were washed and incubated with mabs for one hour at room
temperature. For detection of OX40-Fc, a goat anti-human IgG-HRP
(Southern Biotech, Birmingham, AL, USA) was used, whereas
OX40L-FLAG was identified by a murine anti-FLAG® M2-HRP mab.
After repeated washing with PBS-T, protein bands were visualised
Table 1
Sequences of oligonucleotides.
Number Construct Orientationa Sequenceb
2093 OX40L-FLAG f GACAGGTGCAGCTGCAGACAGATTCTCTGCAACTC
2094 OX40L-FLAG r GGTGACACTATAGAATAGGAATTCTATGGGTTGCAAAAGACGG
2101 OX40-Fc f AGCTGGTGCCACGCGGATCCTCGAAATGCAAAGAACATG
2102 OX40-Fc r GCATGTGTGAGTTTTGTCGACAGACCCCCAGTTAGTGCC
2133 HA-SP-Myc CCCAAGCTGGCCTCTGATGGCTATCATCTACCTCATCCTCCTG
TTCACCGCTGTGCGGGGCgaacaaaaactcatctcagaagaggatctaCGCGTA
GGCCAAGCTTGGGGA
2137 OX40-Myc r TCCCCAAGCTTGGCCTATCAGTTTTTTATGAGACTGG
2141 OX40-Myc f atctaCGCGCAGGCCAATCGAAATGCAAAGAACATG
2144 OX40L-V5 f GGATGCATGATGGTGTGTGC
2145 OX40L-V5 r TGGGTTGCAAAAGACGGGAT
a Orientation: f¼ forward, r¼ reverse.
b Sequence: Bold letters mark nucleotides encoding the signal peptide of Hemagglutinin of Influenza A virus. Lower case letters indicate nucleotides encoding the c-Myc tag.
Underlined sequences display overlapping sites with vector arms.
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via chemiluminescense using the MicroChemi 4.2 (DNR Bio-
Imaging Systems, Jerusalem, Israel).
2.8. Staining procedures
Stably transfected 293-OX40-Myc cells were stained with
OX40L-FLAG, followed by a murine anti-FLAG® M2 mab (Sigma
Aldrich) and by a goat anti-mouse IgG1 human ads-APC mab
(Southern Biotech). As negative controls, cells were either stained
with an unrelated FLAG-tagged chicken protein (CD30L-FLAG) fol-
lowed by secondary mabs or solely stained with the secondary
mabs to exclude any unspecific binding to theMyc-tagged receptor.
To verify surface expression of the chOX40-Myc receptor, trans-
fected cells were stainedwith themab 9E10 specifically recognising
the c-Myc tag (Invitrogen life technologies), followed by a goat anti-
mouse IgG1 human ads-APCmab. 293-OX40L-V5 cells were stained
with OX40-Fc and the AF647-conjugated goat anti-human IgG Fcg
specific F(ab')2 fragment (Jackson ImmunoResearch Laboratories
Inc.). As negative control, cells were either stained with an unre-
lated Fc-tagged chicken protein (CD30-Fc) followed by the sec-
ondary mab or solely with the secondary mab. For the affirmation
of OX40L-V5 surface expression, transfected cells were stainedwith
a murine anti-V5-FITC mab (Invitrogen life technologies). To ac-
quire the kinetics of chOX40-Fc staining upon activation, chicken
splenocytes were stained at days 0, 2, 4, 6, 8 and 10 with chOX40-Fc
followed by the AF647-conjugated goat anti-human IgG Fcg specific
F(ab')2 fragment. Double immunofluorescence analysis was per-
formed with OX40-Fc, followed by mabs specifically recognising
chicken TCR1 (gd T cells, murine IgG1) (Sowder et al., 1988), TCR2
(aVb1 T cells, murine IgG1) (Chiak et al., 1988), TCR3 (aVb2 T cells,
murine IgG1) (Chen et al., 1989), and CD8a (3e298, murine IgG2b)
homologues (Luhtala et al., 1997). Subsequently, cells were incu-
batedwith a mixture of the AF647-conjugated goat anti-human IgG
Fcg specific F(ab')2 fragment and depending on the isotype of the
primary mab, either with a goat anti-mouse IgG1 human ads-PE or
goat anti-mouse-IgG2b human ads-PE (both Southern Biotech). For
each staining appropriate isotype matched controls were used. For
life-death staining, either Propidiumiodid (PI) (Sigma Aldrich) or
Fixable Viability Dye eFluor780 (eBioscience GmbH, Frankfurt am
Main, Germany) were used. The population of living cells was
subsequently analysed by flow cytometry (FACS Canto II, Becton
Dickinson) using BD FACS DIVA 6.1.3 software.
3. Results
3.1. Identification of chicken OX40 and OX40L
We searched the chicken genome assembly Gallus_gallus-5.0
for the keywords OX40 and OX40L and obtained the genomic
location for these TNF family members. The chicken OX40 genewas
not discretely listed, but annotated in the database together with
another gene as TNFRSF18. In order to ascertain the identity of the
presumed OX40 gene, so far annotated as TNFRSF18, we screened
the genomic regions containing the supposed OX40 in chicken for
shared synteny with the human andmurine genome and ran BLAST
searches with the predicted coding sequences of the presumed
OX40 gene on chicken genome assembly 5.0. The BLAST search
revealed a hit on chicken chromosome 21, flanked by the two genes
SDF4 and TNFRSF18. Together with OX40, we identified these two
sequences as highly conserved and co-localised genes also on hu-
man chromosome 1 and on murine chromosome 4 (Fig. 1 A). The
OX40L gene is located on chromosome 8 and shares genetic linkage
to the gene of PRDX6. It is also clustered to FasL as a screening of
genomic regions flanking OX40L in human and mouse (both
chromosome 1) revealed (Fig. 1 B).
3.2. Chicken OX40 and OX40L share characteristic sequence
features with their mammalian homologues
The predicted coding sequences of chicken OX40 and OX40L
genes were further compared to their equivalents in other species.
Transcription analysis demonstrated that the DNA sequences
encode for chains of 287 (chOX40) and 204 (chOX40L) amino acids,
respectively. The analysis of OX40 revealed the typical structure of a
type I transmembrane protein with an extracellular domain of 225
amino acids (signal peptide of 28 residues), a transmembrane re-
gion of 23 amino acids and a cytoplasmic domain of 39 amino acids
(Fig. 2). The entire OX40 molecules of the depicted species
comprise 287 (chicken), 286 (turkey), 277 (human) and 272
(mouse) residues. Chicken OX40 displays an overall identity of
about 30% to its human counterpart. The ectodomain of chOX40
exhibits CRDs, representing the characteristic feature of the TNFRSF
family members. Like its homologues, chOX40 contains three
complete (CRD 1, 2, 4) and one truncated (CRD 3) CRDs (Willoughby
et al., 2017). The structure of human OX40 CRDs can be further
characterised and divided into submodules according to the system
established by Naismith and Sprang (1998). The two avian re-
ceptors display the same sequential arrangement of submodules,
thus forming the same disulphide bonds. Their CRD 1 and 2 show
classical A1-B2 modules, their CRD 3 is truncated and only pos-
sesses an A1 module, whereas their CRD 4 contains A1-B1 modules
(Willoughby et al., 2017). Another similarity among the species is
themajor conserved TRAF2 bindingmotif (P/S/A/T) x (Q/E)E in their
cytoplasmic domain, which suggests conserved signalling path-
ways (Ye et al., 1999).
The chicken OX40L molecule displays the structural organisa-
tion of a type II protein with its amino-terminal cytoplasmic
domain of 41 amino acids, its transmembrane region comprising 23
amino acids and its carboxyl-terminal extracellular domain of 140
residues (Fig. 3). The full length sequences of OX40L of chicken,
turkey, human and mouse consist of 204, 204, 183 and 198 amino
acids, respectively. Even though the displayed sequences show an
overall sequence identity of only 19%, the TNF homology domain
(b-strands indicated for huOX40L) with its hydrophobic residues,
assumed to be important for the trimerisation, is well conserved
(Compaan and Hymowitz, 2006). Regarding the intracellular
domain of OX40L, the chicken sequence seems to be longer with an
extra 31 amino acids (MMVCASASTKQARPAGDCGPPVLLVPALLVE).
This may not be the transcriptional start site due to an extra
methionine further 3’ that is exactly in the same position as in
mammals.
3.3. Phylogenetic relation between depicted TNFRSF and TNFSF
family members
Given the low overall sequence identity, we additionally per-
formed phylogenetic analyses to further validate the homology of
the identified genes to their mammalian counterparts using
Maximum Likelihood trees (Fig. 4). Sequences of turkey, human
and mouse were used as far as identified in the database for the
receptor CD30 and its ligand CD30L. Chicken sequences of TACI and
BAFF were included as internal tests for tree construction repre-
senting outliers. The analysis of the receptors (Fig. 4A) shows that
the chicken OX40 is closely related to its species equivalents
forming one cluster, whereas the CD30 receptor molecules are
clustered and chicken TACI exhibits a more distant relation to these
two receptor families. The same phenomenon can be seen for the
phylogenetic analysis of the TNFSF ligands OX40L, CD30L and BAFF
(Fig. 4B). The molecules belonging to the OX40L family are clus-
tered, while the CD30L family forms an individual branch and
chBAFF is only distantly related. Both OX40L and CD30L molecules
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belong to the divergent group of TNFSF ligands and hence share
only weak similarities with each other and with the EF-disulphide
group (e.g. BAFF) (Compaan and Hymowitz, 2006).
3.4. Soluble ectodomains of recombinant chOX40-Fc and chOX40L-
FLAG
We next generated different variants of the chOX40 and of its
ligand chOX40L to assess their mutual binding capabilities and to
investigate their application in the staining of primary chicken cells.
OX40 was generated as soluble Fc-tagged (OX40-Fc) version and
the ligand as FLAG-tagged soluble protein (OX40L-FLAG). Purified
OX40-Fc and OX40L-FLAG were separated by SDS-PAGE under
reducing and non-reducing conditions, subsequently electroblotted
and detected bywestern blot analysis (Fig. 5). ChOX40-Fc shared an
apparent molecular weight of approximately 80 kDa under
reducing and 160 kDa under non-reducing conditions, thus arguing
in favour of homodimerisation (Fig. 5A). In case of chOX40L-FLAG,
the reduced sample revealed an apparent molecular weight of
about 30 kDa and the non-reduced sample of about 60 kDa, hence
as well suggesting homodimerisation (Fig. 5B).
3.5. Interaction between recombinant chicken OX40 and OX40L
To assess the interaction of OX40 and OX40L, we applied ELISA
and flow cytometric analyses. To confirm the interaction between
the soluble forms of chOX40-Fc and chOX40L-FLAG, we performed
an ELISA titration assay (Fig. 6). OX40-Fc was immobilised on a
plate and OX40L-FLAG was added in twofold dilutions. The binding
capability of the soluble OX40L to its receptor declined with higher
dilutions of the ligand. The binding of the OX40L-FLAG-ectodomain
to the ectodomain of its Fc-tagged receptor was specific, as the
ligand showed no significant interaction with an unrelated chicken
Fc-tagged protein (CD30-Fc), even at the highest concentrations.
In order to verify the binding capability of the cell-bound re-
ceptor to the ectodomain of its soluble ligand, we established a
stable cell line of 293 cells expressing the full length, Myc-tagged
OX40 receptor on its cell surface (293-OX40-Myc). Since the vec-
tor also comprised a GFP cassette under a second promotor, the
efficiency of the transfection could be measured. To exclude any
unspecific binding, we included two negative controls using
transfected cells with the secondary mabs, or an unrelated FLAG-
tagged chicken protein (CD30L-FLAG) in combination with the
secondary mabs (Fig. 7). Cells were stained with the mab 9E10 and
screened for their c-Myc expression via flow cytometry. Simulta-
neous screening for their GFP signal revealed that almost all cells
were double positive for 9E10 and GFP expression. Staining with
OX40L-FLAG demonstrated that virtually all cells bearing an OX40-
Myc receptor on their cell surface could be recognised by their
soluble ligand.
Additionally, we tested whether the chOX40-Fc proteinwas able
to detect cell-associated OX40L. For this purpose, we established a
cell line stably expressing the entire OX40L ligand (293-OX40L-V5).
Virtually all transfected cells exhibited cell-bound OX40L-V5
(Fig. 8), whereas isotype matched controls showed no positive
signal. Stainingwith chOX40-Fc yielded a very similar population of
positive cells, compared to the staining with the anti-V5-FITC mab.
Negative controls, either with secondary mab only or in
Fig. 1. Comparative chromosomal organisation of OX40 and OX40L. Sequential arrangement of genomic regions flanking the OX40 (A) or the OX40L (B) gene in human, mouse
and chicken on the respective chromosomes as indicated. Transcriptional orientation of the genes is marked by an arrow. TNFRSF4 (OX40) and TNFSF4 (OX40L) genes are boxed with
a dashed line. Highly conserved flanking genes to OX40 or OX40L are shaded in dark-grey. Gene lengths and distances between individual genes are not drawn to scale. Gaps in gene
order, omitting genes up to the localisation of the FasL gene, are marked by a dashed line. The gene of FasL is shaded in light grey. The entire gene denotations according to NCBI:
TTLL10: tubulin tyrosine ligase like 10, TNFRSF18: TNF receptor superfamily member 18, SDF4: stromal cell derived factor 4, B3GALT6: beta-1,3-galactosyltransferase 6, ARHGEF7L: rho
guanine nucleotide exchange factor 7-like, FASL: Fas ligand, TNFSF18: TNF superfamily member 18, GOT2P2: glutamic-oxaloacetic transaminase 2 pseudogene 2, PRDX6: peroxir-
edoxin 6, SLC9C2: solute carrier family 9 member C2 (putative), TEX50: testis expressed 50, TADA1: transcriptional adaptor 1. Putative additional genes are shown following NCBI
nomenclature: Mouse: GM10560, GM19057, GM31815, GM5704; Chicken: LOC107053928.
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Fig. 2. Amino acid sequence alignment of OX40. Extracellular (EC), transmembrane (TM) and cytoplasmic (CY) domains are indicated and species are denoted as ch, chicken; tu,
turkey; hu, human; mo, mouse. Conserved residues are shaded in grey, asterisks (*) indicate residues sharing similar properties. The signal peptide (SP) is marked by a line and CRDs
by arrows above the sequences. Note that the SP of moOX40 solely comprises amino acids 1e22. Disulphide bridges of CRD submodules are displayed as S-S beneath the sequences.
The dashed line indicates the major conserved TRAF2 binding motif. Accession numbers: chOX40 NP_001341653.1, tuOX40 XP_010721084.1, huOX40 XP_016857721.1, moOX40
NP_035789.1.
Fig. 3. Amino acid sequence alignment of OX40L. Cytoplasmic (CY), transmembrane (TM) and extracellular (EC) domains are indicated and species are denoted as ch, chicken; tu,
turkey; hu, human; mo, mouse. Conserved residues are shaded in grey, asterisks (*) indicate residues sharing similar properties. The b strands of huOX40L are labelled and their
respective residues are marked by arrows above the sequences. Accession numbers: chOX40L XP_430147.2, tuOX40L XP_010714012.1, huOX40L NP_003317.1, moOX40L
NP_033478.1.
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combination with an unrelated Fc-tagged chicken protein (CD30-
Fc), showed no positive staining of transfected cells, thus con-
firming the specificity of the observed interaction between OX40-
Fc and its cell-associated ligand. In conclusion, three different as-
says employing soluble and cell-bound forms of OX40 and its ligand
confirmed their interaction.
3.6. Frequency of chOX40-Fc positive splenocytes increases after
stimulation with IL-2 and IL-12
In order to test the staining capability of the recombinant
chOX40-Fc on primary chicken cells (Fig. 9), chicken splenocytes
were stimulated in vitro by a combination of the cytokines IL-2 and
IL-12, favouring the selective expansion of gd T cells (unpublished
observation). Splenocytes were stained directly after preparation to
measure the fraction of OX40-Fcþ cells in native cells. On day 0, we
observed no significant staining of native chicken splenocytes by
OX40-Fc. In the course of stimulation with IL-2 and IL-12, the
number of cells positively stained increased and reached its peak
after a ten-day stimulation (10,2%). We further characterised the
population of OX40-Fcþ cells by additionally applying different
lymphocyte markers. The results of double staining with OX40-Fc
and mabs specifically recognising chicken TCR1, TCR2, TCR3 and
CD8 are shown in Fig. 9B. On day 10 of the stimulationwith IL-2 and
IL-12, gd T cells bearing the TCR1 receptor, dominated the cell
population. The TCR1þ cells exhibited a subpopulation of cells be-
ing OX40-Fcþ (9,6%), whereas a small percentage of cells were
OX40-Fcþ, but belonged to the subpopulations of ab T cells (TCR2
double positive 1,6%, TCR3 double positive 0,9%). Also the popula-
tion of CD8þ cells was subdivided into a double positive (6,1%) and a
negative (47,1%) subpopulation on the basis of OX40-Fc staining.
We hence showed the applicability of recombinant chOX40-Fc for
the staining of primary chicken cells and confirmed the presence of
OX40-Fcþ cells upon stimulation with IL-2 and IL-12.
4. Discussion
Besides the CD28-B7 system of costimulatory signals, the TNF
superfamily has proven to provide key mediators for T cell activa-
tion in mammals. Even though the functional relationship among
these different TNFRSF receptors or their association to CD28 in the
complex process of T cell activation needs to be further investi-
gated, past studies indicate that the effects of TNF family members
operate at different times during activation, thus enabling a sus-
tained T cell response (Croft, 2003). Especially OX40 and its ligand
OX40L play a major role to ensure the longevity of activated T cells
in mammals.
Various members of the TNF superfamily conserved their
Fig. 4. Phylogenetic comparison of TNFRSF and TNFSF family members. The
external nodes are denoted with the receptor (A) or ligand (B) name and the respective
species: ch, chicken; tu, turkey; hu, human; mo, mouse. The numbers beside the
branches indicate the percentage of trees in the bootstrap analysis in which the
associated species formed a cluster. The tree is drawn to scale and branch lengths
represent the number of substitutions per site. Accession numbers: chOX40
NP_001341653.1, tuOX40 XP_010721084.1, huOX40 XP_016857721.1, moOX40
NP_035789.1, chCD30 XP_015152299.1, huCD30 NP_001234.3, moCD30 NP_033427.1,
chTACI XP_015149738.1, chOX40L XP_430147.2, tuOX40L XP_010714012.1, huOX40L
NP_003317.1, moOX40L NP_033478.1, chCD30L NP_989740.1, tuCD30L XP_010719103.1,
huCD30L NP_001235.1, moCD30L NP_033429.1, chBAFF XP_015129632.1.
Fig. 5. Western blot of OX40-Fc and OX40L-FLAG. Reduced (R) and non-reduced (NR) samples were separated by SDS-PAGE, blotted and recombinant proteins were detected
either by an HRP-coupled goat anti-human-IgG antibody (for OX40-Fc) (A) or by an HRP-coupled mouse anti-FLAG antibody (for OX40L-FLAG) (B).
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genomic collocation during the evolutionary process and thus can
be found in direct proximity to each other in the genome of
different species. According to Ware (2003), this sequential
arrangement of several TNF members is probably due to duplica-
tion and translocation of particular gene loci in a vertebral ancestor.
As their mammalian homologues, the genes of chicken OX40 and
OX40L are clustered with other members of the TNF superfamily
(e.g. OX40 - GITR, OX40L - FasL) within the genomic sequence.
Beyond conserved genomic localisation, chicken OX40 and OX40L
proteins exhibit the typical structural features of their respective
families. Phylogenetic analyses affirm a stronger relation of the
chOX40 and the chOX40L proteins to their respective subfamily in
comparison to other chicken molecules such as CD30, TACI or
CD30L and BAFF. Even though all representatives of the TNFRSF or
the TNFSF share basic, characteristic features across vertebrates, i.e.
the existence of CRDs or a THD domain, the structural specialities of
OX40 or OX40L persist beyond species boundaries, which is re-
flected in the cluster formation in the phylogenetic trees. The poor
Fig. 6. ELISA titration assay of OX40L-FLAG on immobilised OX40-Fc. OX40L was applied in consecutive twofold dilutions (x-axis). The resulting absorbance values are indicated
on the y-axis. As negative control, OX40L-FLAG was applied at the highest concentration on an irrelevant Fc-tagged receptor (CD30-Fc). The error bars display the standard de-
viations of triplicates.
Fig. 7. Flow cytometric analysis of OX40L-FLAG interaction with cell bound OX40-Myc receptor. Top row: staining control of OX40-Myc, GFPþ transfected cells (only secondary
mabs applied) and staining control comprising an unrelated FLAG-tagged chicken protein (CD30L-FLAG) and secondary mabs; bottom row: recognition of the Myc-tag of OX40-Myc,
GFPþ transfected cells by 9E10 mab; OX40-Myc cells screened for their interaction with soluble OX40L-FLAG in combination with GFP signal.
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Fig. 8. Flow cytometric analysis of OX40-Fc interaction with cell bound OX40L-V5 ligand. Top row: staining control of OX40L-V5 transfected cells (only secondary mab applied)
and staining control comprising an unrelated Fc-tagged chicken protein (CD30-Fc) and the secondary mab; bottom row: recognition of the V5-tag of OX40L-V5 transfected cells by
an anti-V5-FITC mab; OX40L-V5 cells stained with soluble OX40-Fc and secondary mab.
Fig. 9. OX40-Fc staining on stimulated chicken splenocytes. Kinetics of chOX40-Fc staining upon activation on chicken splenocytes (A). Splenocytes, stimulated with IL-2 and IL-
12 (in long-term culture) were analysed for their interaction with recombinant chOX40-Fc by flow cytometry at different times as indicated. Percentages indicate the fraction of
cells, which were positively stained with OX40-Fc. Double staining of splenocytes at day 10 in culture with IL-2 and IL-12 (B). Cells were analysed for their interaction with OX40-Fc
in combination with different mabs as indicated. Percentages display the fraction of positive cells in the respective quadrants. All markers were based on isotype-matched controls.
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overall identity (30%) between human and chicken OX40 amino
acid sequences is not surprising, as chicken molecules frequently
share poor sequence homology with their mammalian equivalents
(Abdalla et al., 2004). Conserved residues among the species are
especially concentrated to the N terminus, which is also evident for
the chicken CD30 molecule (Burgess et al., 2004). The ectodomain
of the chicken receptor exhibits three complete and one truncated
CRD, which is characteristic for the OX40molecule and causal for its
elongated shape (Naismith and Sprang, 1998; Willoughby et al.,
2017). Complying with the structural requirements, it is likely
that the chicken OX40 interacts with its ligand in a 3:3 ratio as it is
reported for mammals (Compaan and Hymowitz, 2006). Binding of
chOX40 probably results in anti-apoptotic signals similar to those of
mammalian OX40, as it shares the TRAF2 binding motif which is
important for the intracellular signal cascade (Ye et al., 1999).
In comparison to the chOX40 molecule, chOX40L protein shares
even less sequence identity (19%) with its human equivalent. Mu-
rine and human molecules also display only 40% sequence ho-
mology, which is considerably less compared to the homologies
among other TNFSF ligands of these species (Willoughby et al.,
2017). However, the existing structural similarities between
mammalian and chicken ligand argue for a similar functional
behaviour. As in mammals, the hydrophobic properties of the
chicken OX40L THD probably allow for trimerisation (Compaan and
Hymowitz, 2006). Mammalian OX40 and OX40L are reported to
solely bind to each other showing no interaction with other
members of the TNF superfamily. In mammals, TNF was demon-
strated to bind TNFR-1 and TNFR-2 (Idriss and Naismith, 2000)
whereas BAFF was reported to interact with three receptors,
namely BAFFR, TACI and BCMA in mammals and with BAFFR and
TACI in chickens (Reddy et al., 2008). The exclusive binding of
OX40L to OX40 receptor in mammals probably is the result of the
atypical assembly of the OX40-OX40L complex in comparison to
other TNF members (Compaan and Hymowitz, 2006). To investi-
gate the mutual binding capabilities of chicken OX40 and its ligand
OX40L, we pursued three different approaches. In an ELISA titration
assay, we demonstrated the specific binding capability of the sol-
uble ectodomains of the receptor and its ligand. To further support
these results, we verified their interaction via flow cytometric an-
alyses and showed that cell-bound receptors were recognised by
their soluble ligands and vice versa. Since the chicken CD30 and
CD30L molecules, applied as negative controls in these assays,
revealed no interaction with OX40 and OX40L, respectively, it is
possible that also chOX40 and chOX40L exclusively interact with
each other.
By western blot analyses, we further characterised the soluble
chicken proteins under reducing and non-reducing conditions. Due
to four glycosylation sites within the ectodomains of OX40 and
OX40L, and one site in the Fc-tag, the observed molecular masses of
reduced samples exceeded the calculated values for monomers
(47 kDa for OX40-Fc and 17 kDa for OX40L). As expected, the
extracellular domain of OX40 formed dimers because of the
dimerising Fc domain of human IgG1. Likewise, the OX40L-FLAG
molecule revealed bands arguing for the dimerisation of the
molecule. This is in linewith studies inmammals, revealing that the
trimerisation rate of recombinant, tagged THDs of some TNF li-
gands, e.g. GITRL, is rather low (Wyzgol et al., 2009).
Since only few mabs are available to characterise cell pop-
ulations in the chicken (Kaiser, 2012), we finally tested the appli-
cation of recombinant OX40-Fc protein in the staining of primary
chicken cells. Screening of native chicken splenocytes, bursal cells,
thymocytes, PBL, PBMC, as well as in vitro cultured macrophages
and HD11 cells yielded no positive cell population for OX40-Fc
(data not shown). This finding agrees with reports in human and
mouse that OX40L expression is restricted to activated APCs and
activated T cells (Watts, 2005).
Besides their involvement in ensuring the longevity of ab T cells,
OX40-OX40L signalling is probably an important way of activation
also in gd T cells (Brandes et al., 2003). T cell-T cell interactions via
OX40L expressed on activated gd T cells may occur in a similar way
as observed for ab T cells (Mendel and Shevach, 2006). In contrast
to humans and mice, which are categorised as gd low species,
chickens represent one of the species (among sheep, cattle, pigs
and rabbits) which displays high levels of gd T cells (Su et al., 1999).
Therefore, we selected chicken gd T cells to assess the involvement
of OX40-OX40L system in the process of T cell activation in the
chicken.We demonstrated that in the course of stimulationwith IL-
2 and IL-12, chicken gd T cells, including a CD8þ subset, upregulate
OX40L, probably in order to sustain an activated state via T cell-T
cell interactions, as reported for mammalian T cells (Mendel and
Shevach, 2006).
In conclusion, our results argue for an important role of the
OX40-OX40L system in the process of T cell activation in the
chicken. We demonstrated the tight phylogenetic and structural
relationship of chickenmolecules to their mammalian homologues,
suggesting similar anti-apoptotic functions. Furthermore, we
confirmed the interaction of chicken proteins in three different
assays and displayed the application of recombinant chOX40-Fc in
the staining of primary chicken cells. The cell-bound variants of
chicken OX40 and OX40L represent suitable tools to generate mabs
to further characterise the expression pattern of the chicken mol-
ecules, e.g. on activated CD4þ cells and to generally enlighten the
role of chOX40 and its ligand OX40L in the chicken T cell response.
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5 Discussion
5.1 Costimulatory signals in T cell activation in chickens
Secondary signals via different types of costimulatory molecules, accompanying
TCR triggering, are essential for the generation of a fully effective T cell response
in mammals as well as in chickens. Regarding mammals, many studies so far have
investigated the process of T cell costimulation. They focussed on central aspects,
such as the identity of the involved molecules, their mutual interactions, downstream
signalling events and their functional implication in T cell activation.
Even though the avian and mammalian lineages split approximately 310 million
years ago in the evolutionary process, chickens and mammals share many mech-
anisms and properties of an effective T cell response [5, 10]. Chickens generally
display the major biomolecules involved in the generation of a potent, but equally
balanced T cell response, which are described for mammals. The main three su-
perfamilies of costimulatory molecules for T cells, namely the immunoglobulin su-
perfamily, the family of cytokine receptors and the tumour necrosis factor receptor
superfamily, exist in both chickens and mammals and seem to fulfil similar func-
tions.
The most prominent members of the immunoglobulin family, CD28 molecule and
its ligands CD80 and CD86, were identified in the genomes of chicken, turkey and
zebra finch [10] and CD28 was characterised for the chicken. Its expression on αβ
and γδ T cells, as well as its ability to stimulate T cell proliferation and IFNγ pro-
duction seems to be conserved among chickens and mammals [34, 174]. With ICOS
and CD2 [10, 23], two other important costimulatory molecules of the IGSF have
been identified in chickens.
Similarly, different chicken cytokines (e.g. IL-2, IL-12 and IL-15) have been de-
scribed and were reported to function as major T cell growth factors [175, 176].
The ability of chicken IL-2 and IL-12 to favour cell proliferation was demonstrated
in our culturing system of γδ T cells.
Since the decoding of the chicken genome [177], different members of the TNF su-
perfamily were genomically identified for the chicken, where their number seems
to be restricted in comparison to the known repertoire in mammals [178]. Both
mammals and chickens display TNF genes in certain sub-groups of collocated genes
[178]. Some of these sub-groups could not be identified via shared synteny yet, as
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the regions in the chicken genome are strongly rearranged compared to the mam-
malian genome [178]. It is still not clear whether some of the missing subfamilies
can be tracked in the future or whether further genomic and functional analyses will
confirm their absence in the chicken. Compared to the 19 ligands and 29 receptors
noted for the human genome, up to now, 15 receptors and 10 ligands have been
identified for the chicken genome [179]. Only few of them have been further charac-
terised yet, like the ligand BAFF [180] and its receptors Transmembrane Activator
and Calcium Modulating Ligand Interactor (TACI) and BAFFR [181], CD40L [182]
and CD40 [183], Receptor Activator of Nuclear factor κB Ligand (RANKL) and its
receptors Receptor Activator of Nuclear factor κB (RANK) and OPG [179, 184] or
CD30L [185] and its receptor CD30 [186].
However, CD30 and its ligand CD30L, have remained the only representatives of
the chicken TNF superfamily whose involvement in T cell costimulation has been
described so far. Even though their respective expression patterns generally ap-
pear similar to those in mammals [185, 186], their functional implication is still
unknown. As both molecules were characterised independently, no information is
available concerning their ability of mutual binding and consequential effects of their
interaction. For this work, CD30 and CD30L were cloned from chicken complemen-
tary DNA (cDNA) of Concanavalin A (ConA) stimulated T cells and constructs
were generated based on the recombinant soluble variants of OX40 and OX40L to
serve as controls within the demonstrated experiments.
As OX40 and OX40L adopt a major role in the process of T cell activation in mam-
mals, this study focussed on their identification and characterisation in chickens.
This work compares chicken OX40 and OX40L with their mammalian counterparts
and illustrates their tight structural and phylogenetic relation. It further demon-
strates their mutual interaction as soluble and cell-bound molecules and proves the
expression of OX40L on chicken αβ and γδ T cells.
5.2 Genomic identification of chicken OX40 and OX40L
Both chicken molecules were identified by keyword search in the genome assembly
Gallus gallus-5.0 and correctly assigned to their mammalian homologues by virtue of
shared synteny with collocated genes and homology search using murine and human
sequences. In this process, the chicken homologues for the costimulatory molecule
GITR (chromosome 21) and its ligand GITRL (chromosome 8) were also identified
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and equally allocated to their mammalian counterparts. The genes for Stromal Cell
Derived Factor 4 (SDF4) and GITR, also annotated as TNFRSF18, flanked the gene
of OX40 within the human (chromosome 1), murine (chromosome 4) and chicken
(chromosome 21) genome. Analogously, the gene of OX40L was linked to the gene
of Peroxiredoxin 6 (PRDX6) and clustered to the genes of GITRL (TNFSF18) and
FasL in all three species (chicken chromosome 8, human and murine chromosome
1). The genes of TNF ligands and TNF receptors probably originated from gene
duplication and translocation of specific gene loci in a former vertebral ancestor and
retained their respective collocation during the evolution of vertebrates [76]. This
phenomenon was also confirmed for OX40 and OX40L molecules and can help to
identify further TNF family members in the chicken.
5.3 Phylogenetic and structural analyses of OX40 and OX40L
Besides conserved genomic localisation, we demonstrated the conservation of the
overall structure and molecular topology between avian and mammalian OX40 and
OX40L molecules via amino acid sequence alignments. Both chicken proteins ex-
hibit characteristic features of the TNF receptor and the TNF ligand families and
share the structural specialities of their mammalian equivalents.
Chicken and turkey OX40, as type I transmembrane proteins, exhibit the charac-
teristic CRD in the N-terminal, extracellular domain. Like their mammalian coun-
terparts, chicken and turkey OX40 possess three complete (CRD1, CRD2, CRD4)
and one truncated CRD (CRD3), which argue for an elongated shape as it is re-
ported for mammals [78, 90]. According to the system established by Naismith and
Sprang [73], these CRD are further divided into submodules, based on the num-
ber of cysteine residues and the topology of disulphide bonds. The arrangement
of submodules of the chicken OX40 molecule is also similar to the human protein
[78], as illustrated in Fig. 4. While CRD1 and 2 display A1-B2 modules, CRD3 is
truncated with only an A1 module and CRD4 shows A1-B1 modules. Conserved
residues among the depicted species concentrate in this N-terminal, extracellular
region, which was also reported for chicken CD30 [186], BAFFR and TACI [181].
As shown for OX40 in this study, also chicken BAFFR and TACI exhibit the same
number of CRD like their mammalian homologues [181]. In contrast, the trans-
membrane and the intracellular region of chicken OX40 display only minor levels of
homology. However, poor sequence similarities are not unusual for chicken proteins
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[6, 185], which reflects in the overall low identity of 30% of chicken OX40 with its
human counterpart. Frequently, the high sequence identity seems to be dispensable,
as long as functionally relevant motifs are preserved among species. The conser-
vation of characteristic features was already shown for other chicken equivalents of
the TNFRSF. The cytoplasmic domain of the CD30 protein e.g. harbours a se-
quence of 22 amino acids highly conserved among chickens, mice and humans [186].
Even though its functional impact remains unclear, its importance is emphasised
by the otherwise prevailing low sequence similarity within the C terminus. Other
motifs, which are conserved beyond species boundaries within the generally vari-
able intracellular domains of chicken CD30 [186], BAFFR, TACI [181] and OX40
receptors, are the binding motifs for TRAF adaptor proteins. Preservation of these
motifs in chicken molecules argues for conserved signalling pathways and conse-
quently for similar functions. The TRAF2-binding motif, present in the chicken
OX40 intracellular domain, potentially allows for anti-apoptotic signals, mediated
through TRAF2 and other associated TRAF proteins, which is described for mam-
malian OX40 [104, 108]. It is likely that chicken OX40 also sustains T cell activation
by providing survival signals and enhances cell proliferation, differentiation and cy-
tokine production. Some signalling components of the TNFRSF, like TRAF3 [187]
and TRAF5 [188] have already been characterised for the chicken, as well as for
other birds like pigeons (TRAF3) [189] and ducks (TRAF6) [190]. In addition to
structural similarities of mammalian and avian receptor molecules, the conservation
of downstream signalling molecules, exhibiting strong homology levels, renders sim-
ilar effector functions of avian TNFRSF most likely. The chicken molecules OX40,
BAFFR and TACI therefore exemplify the preservation of molecular topology and
probably of functionality since the divergence of mammals and birds about 310 mil-
lion years ago. Phylogenetic analyses also confirm the tight relation of chicken OX40
and OX40L to their respective receptor or ligand subfamilies within the superfamily
of TNF receptors and TNF ligands. Even though all depicted receptors and their
respective ligands share the common features of their superfamilies (CRD or THD),
the topological specialities of OX40 and OX40L molecules persist beyond species
boundaries. This also reflects in the cluster formation in the phylogenetic diagrams:
OX40L and CD30L molecules e.g. are part of the divergent group of TNF ligands
and thus exhibit only poor homology levels among each other and with BAFF from
the EF-disulphide group.
Compared to its receptor, the chicken OX40L exhibits an even poorer sequence
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identity to its human equivalent, namely 19%. A comparatively poor homology
level of 40% was described for human and mouse molecules, two species, which nor-
mally share considerably higher sequence identities [78]. These very low identity
values among species seem to be molecule-specific and cannot be extrapolated to
other TNFSF members, as e.g. other chicken ligands share normal (CD30L, 36%)
or even high (TNF-Related Apoptosis-Inducing Ligand, TRAIL, 56%; BAFF, 76%)
sequence identity with their respective human counterparts [180, 185]. Despite its
low homology levels, chicken OX40L displays the characteristic structural features
of the mammalian protein, suggesting similar functional properties. The chicken
protein is a type II transmembrane protein with an N-terminal intracellular do-
main and a C-terminal extracellular THD, similar to other chicken TNF ligands
(CD30L, TRAIL, BAFF and RANKL) [180, 184, 185]. With regard to the intra-
cellular domain of OX40L, the original chicken sequence obtained from cDNA was
N-terminally elongated by 31 amino acids (MMVCASASTKQARPAGDCGPPVL-
LVPALLVE) compared to the version depicted in the publication [191]. Alignments
with and without this additional sequence however revealed that the first methion-
ine residue of the elongated chicken sequence probably does not represent the actual
transcriptional start site. The DNA sequence further 3’ exhibits an additional start
codon, which exactly matches the position in mammals and generates the shorter,
only 41 amino acid long version of the chicken cytoplasmic domain. Both chicken
and turkey OX40L molecules share the overall compactness and the short linker
between the extra- and the transmembrane region with their mammalian counter-
parts [90]. In contrast, mammalian and chicken CD30L for instance, display an
elongated connection between the transmembrane domain and THD, evident in the
amino acid sequence alignment of Abdalla et al. [185] and in accordance with the
prediction by the Simple Modular Architecture Research Tool (SMART) [192].
Even though generally only few residues are conserved between chicken and mam-
malian molecules, the extracellular region of chicken OX40L forming the THD shares
important properties with the other species. It comprises hydrophobic residues,
which are assumed to be necessary for trimerisation of the protomers in human
and mouse. It additionally displays residues sharing very similar biochemical prop-
erties with the sites involved in β-strand formation in human OX40L [90], further
supporting its general capability to trimerise.
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5.4 Dimerisation of recombinant soluble OX40 and OX40L variants
Western blot analyses of the extracellular FLAG-tagged chicken OX40L domain
however revealed bands arguing for the dimerisation of the molecule, as it was
estimated and observed for the Fragment crystallisable (Fc)-tagged extracellular
domain of its receptor. Wyzgol et al. [193] also described the propensity of some
recombinant, tagged TNF ligands, e.g. GITRL, to dimerise, instead of forming the
predicted trimers. Likewise, Corti et al. [194] reported the dissociation of ligand-
trimers at low concentrations. This behaviour possibly represents a way to modu-
late their functional impact by altering the quaternary structure in vivo. To favour
trimerisation by recombinant proteins in vitro and to stabilise their oligomeric state
for therapeutic applications, different trimerisation domains can be linked to the
THD: a Tenascin C (TNC) domain [195], a leucine zipper motif [196], as well as
an isoleucine zipper motif [197]. For instance, the linkage of a TNC domain to
the chicken OX40L THD domain would probably ensure its trimerisation, as it is
reported for other mammalian TNF ligands [193]. The generation of recombinant
OX40L trimers may be advantageous for the staining of chicken cells or for investi-
gating its activation potential upon OX40 binding.
5.5 Interaction of chicken OX40 and OX40L
Meeting the topological requirements, chicken OX40 and OX40L are likely to inter-
act in a 3:3 stoichiometry in vivo, as it is reported for their mammalian homologues
[90] and TNF superfamily members in general. For humans and mice, Compaan et
al. [90] demonstrated that binding of OX40L to its receptor differs from the inter-
action between other ligand-receptor pairs. Murine and human OX40 and OX40L
molecules display a special way of assembling into a complex of 3:3 proteins, com-
pared to other molecules like CD40 and CD40L. Upon interaction, the angle between
OX40L protomers and the trimer axis differs from other TNF members by 15◦ and
the size of the trimer interface of the OX40L complex is smaller [78, 90]. Prob-
ably due to this atypical way of interaction between mammalian OX40 and OX40L,
both molecules are reported to exclusively bind each other [115]. In contrast, other
members of the TNF superfamily interact with several distinct partners in mam-
mals as well as in chickens. The range of interaction may be conserved beyond
species boundaries or may differ between mammals and chickens. The interaction
64
between RANKL and its receptors RANK and OPG constitutes an example for
the former case, as their mutual binding and their functional effects are conserved
between chickens and mammals [179]. Chicken BAFF on the contrary, seems to
lack one of its binding partners in comparison to mammalian BAFF. In human and
mouse, BAFF interacts with three receptors, namely BCMA, TACI and BAFFR.
In chickens, only TACI and BAFFR were identified and characterised, whereas the
chicken BCMA gene is disrupted by a termination codon, therefore representing
only a remnant of the mammalian gene [181].
In this work, we used three different approaches to verify the mutual binding capa-
bilities of chicken OX40 and OX40L. The generation of differently tagged receptor
and ligand variants, either soluble or cell-bound forms, helped to independently con-
firm their specific interaction via ELISA (Enzyme-Linked Immunosorbent Assay)
and via flow cytometric analyses. Suitable variants of chicken CD30 and CD30L
molecules showed no interaction with the OX40 or the OX40L molecules. Only re-
cently, we acquired data (unpublished), which suggest that chicken OX40 may have
an additional binding partner. To further characterise the activation process of
chicken T cells, we generated soluble and cell-bound variants of two other chicken
TNF family members, GITR and GITRL, based on the recombinant proteins of
OX40 and OX40L. In flow cytometric experiments, the soluble variant of chicken
FLAG-tagged GITRL was able to bind the stably expressed, c-Myc-tagged chicken
OX40 receptor. It even displayed a higher binding capability to OX40 than the
FLAG-tagged OX40L. The latter was also able to recognise the c-Myc-tagged GITR
receptor, but to a much lesser extent. As GITRL is also reported to solely interact
with its designated receptor GITR in mammals [68], the interaction between chicken
GITRL-OX40 and OX40L-GITR would imply an unknown link between these two
costimulatory systems. Since GITR and GITRL likewise function as costimulators
for T cells and for APC in mammals [198, 199], their functional connection to the
OX40-OX40L system in chickens appears plausible. GITR is detected on näıve
T cells at low levels [198] and is also constitutively expressed on Treg [200]. As
reported for OX40, the GITR expression on CD4+ and CD8+ T cells is vigorously
induced upon T cell activation for several days [201]. Both OX40 and GITR inter-
act with the intracellular adaptor protein TRAF2 in T cells and promote CD4+
and CD8+ T cell proliferation and cytokine production [198, 201]. GITR however,
is also reported to induce apoptosis, depending on the level of T cell stimulation
[202]. GITRL was demonstrated to be expressed by B cells, macrophages and den-
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dritic cells, which upregulated the ligand upon lipopolysaccharide stimulation only
for a brief period [202]. Moreover, GITRL expression was reported for endothelial
cells and for activated CD4+ and CD8+ T cells, but not for näıve T cell subsets
[201–203]. Perhaps, the overlapping interaction between the two systems OX40-
OX40L and GITR-GITRL in chickens serves as a way to modulate costimulatory
signals in a dose-dependent, temporal or spatial manner, as GITRL expression in
mammals seems to be more restricted than OX40L expression. Despite these in-
teresting findings, additional experiments, based on different approaches such as
ELISA or further flow cytometric analyses, have to verify this special link between
the OX40-OX40L and GITR-GITRL systems in chickens.
5.6 Staining of chicken cells with recombinant OX40-Fc
After having confirmed the mutual binding capability of the recombinant chicken
OX40 and OX40L proteins, we assessed an application of the recombinant molecules.
Since only few monoclonal antibodies are available to characterise different cell pop-
ulations and cell subpopulations in chickens [204], we tested the application of sol-
uble, Fc-tagged OX40 in the staining of primary chicken cells. As expected from
studies in mammals, which report the expression of OX40L being restricted to ac-
tivated APC and activated T cells [62], also here, the screening of native chicken
bursal lymphocytes, thymocytes, Peripheral Blood Lymphocytes (PBL), Peripheral
Blood Mononuclear Cells (PBMC), splenocytes, HD11 cells and in vitro cultured
macrophages yielded no OX40-Fc positive (OX40-Fc+) cells. In mammals, the
OX40-OX40L system is not only assumed to provide important costimulatory sig-
nals to αβ T cells, but also to γδ T cells [28]. The OX40L molecule may also be
upregulated on activated γδ T cells to provide costimulatory signals via T cell-T cell
contact, as it is described for αβ T cells [152]. As chickens naturally display high
numbers of γδ T cells [13] in contrast to humans and mice, we selected chicken
γδ T cells to investigate the involvement of OX40 and OX40L in the process of
chicken T cell activation. In the course of stimulation with the chicken cytokines
IL-2 and IL-12, which selectively favours the expansion of γδ T cells in cultures
of native chicken splenocytes, we demonstrated that γδ T cells upregulate OX40L.
While native splenocytes exhibited no OX40-Fc+ cells on day zero of stimulation,
the number of activated T cells expressing OX40L increased up to 10,2% on day ten
of culture. We further characterised the population of OX40L-expressing cells by us-
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ing additional lymphocyte markers, namely TCR1 (for γδ T cells) [205], TCR2 (for
T cells exhibiting the variable (V) chains α and β1, VαVβ1) [206], TCR3 (for VαVβ2
T cells) [207] and CD8 (for cytotoxic T lymphocytes) [208]. Due to the culturing
conditions with IL-2 and IL-12, the population of T cells, further investigated by
double staining, mainly consisted of γδ T cells (TCR1+) and harboured only a low
percentage of αβ T cells (TCR2+ or TCR3+). Nevertheless, some of the remnant
αβ T cells expressed OX40L upon stimulation, as it is reported for mammals [152].
Surely, additional experiments, selectively stimulating the expansion of chicken αβ
T cells, e.g. by the application of anti-TCR2 antibodies, are necessary to verify
these initial indications and to investigate the role of T cell-T cell interactions via
the OX40-OX40L system in chicken αβ T cells, including CD4+ as well as CD8+
subsets. As both subpopulations seem to be affected by costimulatory signals via
OX40 and OX40L molecules in mammals [125, 127], the prevailing ratio of these
cells in chickens would be of great interest. However, as the culture with IL-2 and
IL-12 practically yielded no CD4+ cells, we confined our analysis of OX40L expres-
sion to the CD8+ cell subset and demonstrated that a fraction of CD8+ cells was
also OX40-Fc+. Besides the small subpopulation of αβ T cells and the fraction of
CD8+ cells, also a portion of γδ T cells were OX40-Fc+, suggesting that also chicken
γδ T cells upregulate OX40L in the process of activation to support the longevity
of the activation state by T cell-T cell interactions. For human γδ T cells, it was
already shown that they upregulate OX40 upon activation with phosphor-antigen,
as well as other costimulatory TNF family members, like 4-1BBL and CD27L [28,
209]. As CD8+TCR1+ cells constitute the cell population in the chicken spleen with
major cytolytic activity [210], costimulatory signals via OX40-OX40L interactions
could represent one important way to increase or sustain their effector functions.
Besides OX40L expression, the expression pattern of the OX40 molecule in chickens
is another interesting topic, as the period of cell surface expression upon stimula-
tion in mammals is rather narrow [63, 115, 125]. Differences in the extent of OX40
and OX40L upregulation on activated T cells could be estimated under the influ-
ence of different stimulants such as ConA or activating antibodies like the anti-CD3
antibody. In this context, OX40- and OX40L-bearing cells could be further charac-
terised by different markers via flow cytometry, as it was demonstrated in this work
for OX40L in the γδ T cell culture with IL-2 and IL-12.
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5.7 Outlook
In addition to the use of recombinant proteins, the generation of antibodies specifi-
cally recognising chicken OX40 receptor or its ligand OX40L, would be advantageous
to characterise the impacts of the OX40-OX40L system in the chicken in more detail.
As already mentioned above for non-altered, recombinant ligands, a certain portion
of the recombinantly expressed protein may dissociate and thereby lose its abil-
ity to bind its counterpart on primary chicken cells. Surely, this possibly reduced
interaction represents a limit of staining with recombinant protein. Especially if
the expression of the targeted molecule is rather low, the staining with recombi-
nant protein may then fail to detect it. In contrast, molecule-specific antibodies
can detect the target molecule more precisely. Moreover, monoclonal antibodies
can facilitate the screening of different chicken cell populations and allow for their
characterisation by multicolour staining. Antibodies with activating or inhibiting
properties specifically binding OX40 and OX40L can furthermore shed light on their
effects concerning cell proliferation, differentiation and cytokine production in both
the receptor- and the ligand-expressing cells. After stimulation via OX40-binding
antibodies, flow cytometric analyses could potentially help to phenotypically char-
acterise the evolving effector T cell subsets and to estimate their cytotoxic poten-
tial via cytotoxicity assays. In addition, quantitative Polymerase Chain Reaction
(qPCR) analysis or cytoplasmic cytokine staining via flow cytometry could inform
about the production of different cytokines following OX40 stimulation. The cell
lines generated within this study, stably expressing OX40 and OX40L, respectively,
can be used as tools to generate such monoclonal antibodies or to screen existing
antibodies with unknown specificity for OX40 and OX40L recognition.
Similarly, screening of uncharacterised monoclonal antibodies derived from a fu-
sion with chicken γδ T cells, already yielded the antibody 9C5, which specifically
recognises GITR-Myc-expressing cells (unpublished data). The latter were gener-
ated in the course of establishing the OX40-Myc-expressing cells during this study,
as mentioned above. The specificity of 9C5 to the GITR molecule was verified by
isotype-matched controls. First experiments with this antibody revealed an expres-
sion of GITR on activated γδ T cells, which were cultured with IL-2 and IL-12 and
co-expressed OX40L. Activated γδ T cells apparently express the GITR molecule to
a great extent, whereas native chicken splenocytes exhibited only a minute expres-
sion. Further experiments will be necessary to describe its expression pattern, to
68
estimate its functional role in T cell costimulation and its link to the OX40-OX40L
system in chickens. In summary, our results prove the existence of the OX40-OX40L
system in chickens and provide the recombinant variants of OX40 and OX40L as
useful tools to further characterise the involvement of the OX40-OX40L system in
chicken immune response.
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6 Summary
Characterisation of chicken OX40 and OX40L
Among the costimulatory members of the tumour necrosis factor superfamily, the
OX40 molecule and its ligand OX40L play a decisive role in the formation and the
regulation of an efficient immune response upon antigen encounter. In mammals,
their interaction allows for a sustained T cell response by providing anti-apoptotic
signals as well as by promoting cytokine production, cell proliferation and differen-
tiation. In chickens, however, the information on costimulatory signals accompany-
ing TCR stimulation remains scarce.
This study aimed at the characterisation of chicken OX40 and OX40L to gain more
information about the complex process of T cell activation in chickens.
We identified the genes of chicken OX40 and OX40L in the chicken genome and con-
firmed their correct annotation by virtue of shared synteny with respective flanking
genes in the genomes of human and mouse. The obtained sequences were further
analysed for their phylogenetic and structural relationship to other members of the
TNF family in birds and mammals. The analyses revealed a tight topological rela-
tion of chicken OX40 and OX40L to their respective homologues in other species.
The conservation of a functionally relevant motif among species suggests that the
OX40-OX40L system preserved its functions during evolution. After the cloning
and the recombinant expression of soluble and cell-associated variants, we verified
the mutual interaction of chicken OX40 and OX40L via ELISA and flow cytometric
analyses and demonstrated that both soluble recombinant proteins tend to dimerise.
As only few antibodies are available to characterise chicken cell types, we proved
the application of recombinant OX40-Fc in staining of chicken cells. While OX40L
could not be detected on non-activated cells, OX40L was upregulated on αβ and γδ
T cells upon activation by IL-2 and IL-12. These findings confirm the existence of
the OX40-OX40L system in chickens and suggest their involvement in the activation
process of chicken T cells.
Eventually, soluble and cell-bound variants of OX40 and OX40L, generated within
this study, may serve as new tools to further characterise the involvement of the
OX40-OX40L system in chicken T cell response.
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7 Zusammenfassung
Charakterisierung von OX40 und OX40L beim Haushuhn
Innerhalb der Gruppe der kostimulatorischen Moleküle der Tumor-Nekrose-Faktor
Superfamilie nehmen OX40 und sein Ligand OX40L eine besondere Rolle ein, da
sie maßgeblich zur Entstehung einer Immunantwort nach Antigenkontakt bezie-
hungsweise zu deren Regulation beitragen. Bei Säugetieren erhält die Interak-
tion von OX40 und OX40L den Aktivierungszustand von T-Zellen aufrecht, indem
sowohl Überlebenssignale und Zytokinproduktion, als auch Zelldifferenzierung und
-proliferation gefördert werden. Beim Haushuhn ist jedoch bisher bezüglich der ko-
stimulatorischen Signale, die mit der Stimulation des T-Zell-Rezeptors einhergehen,
wenig bekannt.
Ziel dieser Arbeit war es deshalb, die kostimulatorisch wirksamen Moleküle OX40
und OX40L beim Haushuhn zu charakterisieren, um mehr über den Aktivierungs-
prozess von T-Zellen beim Haushuhn zu erfahren.
Der erste Teil dieser Arbeit beschäftigt sich mit der Identifizierung der OX40-
und OX40L-Gene im Hühnergenom. Dank der Konservierung der Genabfolge in-
nerhalb relevanter Genomabschnitte bei Mensch, Maus und Huhn, konnten die
Gene für OX40 und OX40L beim Huhn identifiziert und richtig zugeordnet wer-
den. Nachfolgende Sequenzanalysen schlossen die Proteinsequenzen anderer Mit-
glieder der TNF-Familie mit ein. Sie verdeutlichten die phylogenetisch enge Ver-
wandtschaft der aviären Moleküle zu ihren Homologen beim Säuger. Ebenso offen-
barten die Analysen der Proteinsequenzen strukturelle Gemeinsamkeiten zwischen
den Molekülen von Vögeln und Säugern, sowie die Konservierung eines Sequenz-
motivs mit funktioneller Bedeutung. Der Erhalt dieses Motivs und des charakteris-
tischen Molekülaufbaus lässt vermuten, dass OX40 und OX40L beim Huhn ähnliche
Aufgaben wie beim Säugetier erfüllen. Die Klonierung und rekombinante Expres-
sion von löslichen und zell-gebundenen Formen der OX40- und OX40L-Moleküle
ermöglichte eine nähere Untersuchung dieser Proteine beim Huhn. So konnte mit-
tels ELISA und Durchflusszytometrie die Interaktion zwischen Rezeptor und Ligand
in drei unabhängigen Versuchen bestätigt werden. Darüberhinaus konnte gezeigt
werden, dass die löslichen, rekombinant hergestellten Proteine Dimere bilden. Da
zur näheren Charakterisierung von Zellen beim Huhn nur eine begrenzte Anzahl an
Antikörpern zur Verfügung steht, wurde in dieser Arbeit gezeigt, dass die lösliche,
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rekombinante Form OX40-Fc geeignet ist, Hühnerzellen für die Durchflusszytome-
trie anzufärben. In diesem Zusammenhang konnte nachgewiesen werden, dass
OX40L, nach Aktivierung durch IL-2 und IL-12, sowohl auf αβ- als auch auf γδ-
T-Zellen des Huhns zu finden ist, wohingegen verschiedene naive Hühnerzellen
OX40L nicht exprimierten. Diese Ergebnisse bestätigen die Existenz des OX40-
OX40L-Systems für das Haushuhn und legen nahe, dass es an der T-Zell-Aktivierung
beteiligt ist.
Darüber hinaus bieten die im Zuge dieser Arbeit hergestellten rekombinanten OX40-
und OX40L-Proteine des Huhns neue Möglichkeiten, den Einfluss des OX40-OX40L-
Systems in der T-Zell-Aktivierung beim Haushuhn näher zu untersuchen.
74
8 References
1. Lowenthal, J., Bean, A. & Kogut, M. What’s so special about chicken im-
munology? Developmental & Comparative Immunology 41, 307–309 (2013).
2. Glick, B., Chang, T. & Jaap, R. The bursa of Fabricius and antibody pro-
duction. Poultry Science 35, 224–225 (1956).
3. Cooper, M., Peterson, R. & Good, R. Delineation of the thymic and bursal
lymphoid systems in the chicken. Nature 205, 143–146 (1965).
4. Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proceedings
of the Royal Society of London Series B (Biological Sciences) 147, 258–267
(1957).
5. Furlong, R. Insights into vertebrate evolution from the chicken genome se-
quence. Genome Biology 6, 207 (2005).
6. Kaiser, P. The avian immune genome - a glass half-full or half-empty? Cyto-
genetic and Genome Research 117, 221–230 (2007).
7. Straub, C. et al. Chicken NK cell receptors. Developmental & Comparative
Immunology 41, 324–333 (2013).
8. Barjesteh, N. et al. TLR Ligands Induce Antiviral Responses in Chicken
Macrophages. Plos One 9, e105713 (2014).
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bedanken. Der wissenschaftliche Austausch ermöglichte es mir, mein Thema aus an-
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